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1 INTRODUCTION 
1.1 Multimodality imaging 
In the last decade, the field of multimodality imaging that combines the varying 
capabilities of multiple sensor types has become of crucial significance to clinical 
in vivo research and practice [1]. Commonly used anatomical imaging technologies 
such as computed tomography (CT) and magnetic resonance imaging (MRI) provide 
structural detail in the order of 0.5-1 mm [2]; whereas functional modalities such as 
positron emission tomography (PET) and single-photon emission computed 
tomography (SPECT) provide insight into the biochemical and physiological functions 
(i.e. metabolism and perfusion) of an organ or tissue. Consequentially, spatial 
co-localization of complementary information (i.e. structure and function) provided by 
two or more modalities ensures a better elucidation of physiological mechanisms at 
molecular and cellular levels. The benefits of integrating different sensory capabilities 
such as contrast, sensitivity, spatial and temporal resolution in relationship to diseases 
while overcoming individual limitations led to the development of many 
instrumentations, such as PET-MRI, SPECT-CT or optical PET. The original concept 
of scanning an object from many angles was presented for the first time by Allan 
Cormack in 1963 [3], and a first prototype of diagnostic CT-SPECT imaging was 
developed in 1966 [4]. However, the need to combine functional and anatomical 
imaging was overlooked until Hasegawa et al. placed a clinical CT in tandem with a 
SPECT camera in the early 1990s [5, 6]. At the same time, a similar concept of 
combining PET and CT was suggested in 1991 [7], although a prototype was not 
completed until 1998. Following several years of obvious concerns with operational 
issues, cost, complexity and reliability, the first PET-CT designs appeared in medical 
centers by early 2001, followed by SPECT-CT designs in 2004 [8]. Since then, their 
use has grown exponentially.  
 
In a similar fashion, multimodal ex vivo tissue analyses that utilize technologies of high 
chemical specificity such as mass spectrometry (MS) for a more detailed 
characterization of the molecular makeup have recently been presented [9-13]. Mass 
spectrometry imaging (MSI) in particular has proven its clinical value, as it can record 
the spatial distribution of hundreds of biomolecules without the need of prior labeling. 
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The acquisition of proteins, metabolites, lipids, peptides and pharmaceuticals directly 
from tissues has been used to examine, among other things, disease-related 
alterations in multiple neurological disorders (i.e. Alzheimer) and cancer types. 
Although the usage of hyperspectral yet slow sensors impedes synchronous 
acquisition as performed during clinical diagnosis, it provides structural and chemical 
information of unparalleled detail in the order of 10-50 μm lateral resolution. 
Concomitantly, asynchronous multimodal tissue diagnoses of unprecedented data 
volumes and acquisition times have been fueling the need for complex post-processing 
transformations to ensure proper image alignment [14-17]. MS, while providing 
chemical-rich information is insufficient to reveal the microscopic structures that are 
observed in established histopathological examinations at a manageable data level. 
Conversely, microscopy-based tissue histology provides precise structural information 
but lacks chemical specificity. Hence, opposing to the conventional approach of fusing 
complementary information into a single hyperspectral plane, an alternate usage of 
multimodality capabilities has emerged. Thereby, spatial dependencies derived from 
one technology are utilized to guide data acquisition and interpretation of one or more 
follow-up modalities [18-20]. Although this extension has seen rapid progress, with its 
positive impact on data load and acquisition time having been demonstrated in 
numerous studies [21], the clinical transfer is still in development.  
 
1.2 FTIR and Raman microscopy 
Vibrational micro-spectroscopic imaging techniques have gained acceptance in many 
fields such as cell biology and nanoscience [22]. The two most common techniques to 
date are imaging Fourier transform infrared spectroscopy (FTIR) and Raman 
spectroscopy. In both of these techniques, the inherent vibrational fingerprint spectra 
of biomolecules are observed.  
1.2.1 History of vibrational spectroscopy in the field of biomedicine 
Although infrared light was discovered as early as 1800 by Sir Frederick William 
Herschel [23], its analytical worth was considered to be irrelevant for many decades. 
In 1928, Sir Chandrasekhara Venkata Raman firstly observed the inelastic scattering 
of a photon by molecules which are excited to higher energy [24]. The effect was 
named after him and Raman spectroscopy was later used to provide the first catalog 
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of molecular vibrational frequencies. However, when IR spectroscopy was revived in 
the 1940s and commercial IR-spectrophotometers became available, Raman 
spectroscopy lost relevance as it needed much higher sample concentration and 
volume in order to maximize sensitivity. The first spectroscopic efforts to analyze 
disease related effects in tissues were described by Blout and Mellors in 1949 [25], 
and Woernley in 1952 [26], who utilized single beam IR spectroscopy for the analysis 
of tissue homogenates. Due to instrumental deficiencies and a lack of methods for the 
interpretation of vibrational spectra at that time, the field was not pursued until the 
1960s. In that time, the advent of laser technology resulted in simplified and more 
sensitive Raman instruments and thousands of studies regarding structure-spectra 
correlation of biomolecules were reported for both infrared and Raman 
spectroscopy [27, 28]. In the 1980s, the acceptance of Fourier transform methodology 
into the field of IR spectroscopy fueled the investigation of bacterial and fungal 
pathogens [29]. Since then, vibrational spectroscopy research aimed at detecting 
diseases in human cells and tissues on the basis of cell pellet experiments until the 
development of micro-spectroscopic methods utilizing a microscope in the 1990s. 
Nowadays, both techniques have gained recognition, among other things, as 
diagnostic tools revealing histopathological features in various disease types [30-34].  
 
1.2.2 Basic principles of vibrational spectroscopy 
Imaging FTIR and Raman microscopy are analytical methods that determine the 
radiation response of matter in a spatially resolved fashion. Whereas FTIR 
spectroscopy measures the absorption of energy at different wavelengths, Raman 
spectroscopy measures the exchange of energy with electromagnetic radiation of a 
particular wavelength, usually mitigated from a near-infrared (NIR) range laser. From 
the exchange in electromagnetic energy a measureable shift in the wavelength of 
incident laser light occurs. This inelastic light scattering effect, known as Raman 
scattering, is complementary to the absorption of infrared radiation.  
 
In imaging FTIR, a screening process is applied in order to construct a spectral map 
that consists of spectra collected from multiple pixels. At each (x,y)-coordinate, multiple 
beams that each consist of complex light frequencies are pointed onto the observed 
specimen and the wavelength-specific absorbance/transmission is recorded. The 
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beams originate from a broadband light source (containing the full measured 
wavelength range) whose light is transmitted into a Michelson interferometer [35]. The 
interferometer consists of a configuration of two mirrors of which one is constantly 
moving and one is fixed, and a beam splitter (Fig 1). The incoming light beam is split 
and in equal parts forwarded to the fixed and moving mirror. Depending on the distance 
between beam splitter and the moving mirror, each wavelength of the reflected and 
recombined light beam is periodically blocked and transmitted due to wave 
interference. The rate at which wavelengths are modulated differs, so that at each 
moment a different excitation spectrum is applied onto the sample. The resulting 
absorption values at many discrete positions of the moving mirror form an 
interferogram that is converted by the eponymous Fourier transform algorithm to 
receive the actual spectrum.  
 
 
Figure 1 Optical arrangement and light path of a Michelson 
interferometer Light of a broadband light source is split and partially 
blocked by a constantly moving mirror to periodically transmit a 
recombined beam consisting of different wavelengths onto a sample. 
In FTIR, the resulting interferogram is converted by Fourier transform.  
 
The recorded absorption pattern allows for conclusions to be made on the specimen’s 
chemical composition as molecules absorb frequencies characteristic of their structure. 
Molecular bonds with an electric dipole moment that can change by atomic 
displacement owing to natural vibrations are IR-active [36]. An IR-active molecule’s 
absorption behavior can differ which results in different vibrational modes (Fig 2). For 
molecules with N atoms, linear molecules feature 3*N-5 different vibrational modes 
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and nonlinear molecules have 3*N-6. The resonant frequencies of each bond are 
related to the masses of the atoms as well as the strength of the bond. Lighter atoms 
and stronger bonds result in higher frequencies, when compared to heavier atoms and 
weaker bonds. Simple diatomic molecules have only one bond and vibrational band 
whereas larger molecules are correspondingly more complex. 
 
 
Figure 2 Vibrational modes of a methylene (-CH2) group. In order for a 
vibrational mode to be “IR-active”, it must be associated with changes in 
the dipole moment. Six vibrations caused by the CH2 moiety, commonly 
found in organic compounds, are displayed (Figure adapted from [37]). 
 
Similar to imaging FTIR, Raman micro-spectroscopy can be applied in a screening 
process. A monochromatic laser is utilized in order to apply light of a specific 
wavelength onto the examined specimen. In biomedical applications, a AlGaAs diode 
with a wavelength of 785 nm is typically utilized, as the use of a lower energy 
wavelengths reduces the risk of damaging the sample [34]. The laser light leads to an 
excitation of (bio)molecular bonds resulting in a red-shift (Raman shift) of some of the 
applied initial radiation that forms a unique fingerprint of peaks. In order to assess the 
Raman shift, the electromagnetic radiation from the illuminated spot is passed through 
a spectrometer, which disperses the light into a spectrum that can be recorded by a 
cooled charge-coupled device (CCD)-camera.  
 
When examining biological materials, imaging vibrational spectroscopy provides the 
ability to visualize the distribution of molecular bonds that are characteristic to 
biochemical classes. Qualitative acquisition of a specimen’s composition occurs in a 
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rapid, label-free and non-destructive manner which makes vibrational spectroscopy a 
powerful technique for in situ analyses. FTIR examination of biological materials 
typically focusses on measuring stretching vibrations such as C-H, S-H, N-H and O-H 
(2550-3500 cm-1), of which for example C-H2 is associated with the fatty acid chains of 
lipids. Other regions of interests are the amide I&II region (1500-1700 cm-1) which 
comprises of protein-associated bond vibrations and the fingerprint region 
(600-1450 cm-1) which comprises of nucleic acid-characteristic P-O and 
carbohydrate-associated stretching vibrations [38]. Together, these regions comprise 
a biochemical signature of interrogated cellular specimen (Fig. 3). 
 
 
Figure 3 Biological infrared fingerprint spectrum showing biomolecular peak assignment.  
Transmission-spectrum of a cryosectioned ductal breast carcinoma in situ. Typical peaks are highlighted, 
where ν = stretching vibrations, δ = bending vibrations, s = symmetric vibrations and as = asymmetric 
vibrations. (Figure adapted from [39]). 
 
Similarly, the Raman spectrum also comprise of vibrational bonds that are associated 
to biochemical classes, as Raman scattering and IR absorption are complementary 
effects [40]. Typical regions of interest are associated to proteins (1500-1700 cm-1), 
carbohydrates (470-1200 cm-1) and phosphate groups of DNA (980, 1080 
and 1240 cm-1). At higher wavenumbers (2700-3500 cm-1), higher-frequency C-H, N-H 
and O-H stretching bonds that are associated with lipids and proteins can be 
recorded [41]. 
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1.2.3 Diagnostic applications of vibrational spectroscopy 
One excellent application field of vibrational spectroscopy imaging is the discrimination 
of specific cell types on the basis of their protein, lipid and carbohydrate profile. Since 
only light is used to record the necessary data, both technologies are entirely non-
perturbing and can be performed complementary to the current practice in 
histopathology. In comparison, each technology has its distinct advantages. Whereas, 
mid-infrared spectroscopy is very sensitive to water interferences that strongly absorb 
radiation, Raman spectroscopy is mostly unaffected, as water is concurrently a weak 
scatterer [42]. For clinical applications, this enables the direct collection in vivo of 
Raman spectra. Moreover, Raman spectroscopy can achieve sub-cellular lateral 
resolution (~300 nm) that is superior compared to FTIR imaging (~10 μm). However, 
the collection of Raman spectra is comparatively more time consuming (1-10 s per 
spectrum), as the Raman effect is relatively weak and only one in ~108 photons 
typically undergoes inelastic light scattering events [34]. For this reason, it is often 
necessary to average a large number of acquired spectra to keep the acquisition time 
manageable. In addition, Raman spectroscopy is very sensitive to fluorescence 
mitigated from biological samples depending on the chosen excitation wavelength.  
 
In the past decade FTIR imaging has been reported as a promising tool for the 
diagnosis of several diseases [43-45], especially for the classification of cancer in 
various tissues (i.e. breast [46-48], colon [49-51], lung [52-54] and prostate [55, 56]). 
Furthermore, the possibility to monitor susceptibility to therapy was recently 
demonstrated in a study from Zawlik et al. who reported discriminatory FTIR features 
for triple-negative breast cancer patients undergoing chemotherapy [57]. In a similar 
fashion, Raman spectroscopy has been used to in vivo investigate cancerous and 
normal cells of skin [58], brain [59] and other tissues (reviewed in [60, 61]).  
 
In addition to its identification and classification capabilities, the non-perturbing nature 
of vibrational imaging spectroscopy makes it particularly interesting for multimodality 
imaging purposes. In that regard, Jermyn et al. recently reported in situ cancer 
detection in brain, lung and colon samples by combining Raman spectroscopy, diffuse 
reflectance spectroscopy and intrinsic fluorescence spectroscopy [62]. Moreover, 
multimodality imaging of frozen head and neck cancer sections by combined Raman, 
fluorescence and second-harmonic generation microscopy imaging was presented by 
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Heuke et al. [63]. In order to assess molecular cancer heterogeneity of a larynx 
carcinoma sample, Bocklitz et al. demonstrated the positive impact of combining 
vibrational Raman spectroscopy and MALDI-MSI [12].  
 
In the case of FTIR, only few multimodal studies have been performed to date. Le 
Naour et al. reported the combination of synchrotron FTIR and synchrotron X-ray 
fluorescence micro-spectroscopy for in situ analysis of a single tissue slide [64]. 
Furthermore, Passot et al. investigated cryotolerance of lactic acid bacteria by 
combined synchrotron FTIR and synchrotron fluorescence microscopy [65]. Following 
the recent trend of predictive multimodality imaging, Großerueschkamp et al. 
presented FTIR-guided laser capture microdissection (LCMD) for subsequent 
proteomic analysis using liquid chromatography – tandem mass spectrometry 
(LC-MS/MS) [20]. This study reflects the high potential and positive impact of guided 
multimodality imaging.  
 
1.3 Mass spectrometry  
In mass spectrometry (MS), the mass of pure chemical species as well as complex 
mixtures is determined by ionization and separate recording of the created ions based 
on their mass-to-charge ratio (m/z). To date, a multitude of techniques for the 
generation of detectable ions as well as for the disaggregation and the measurement 
of m/z-values exist. The most prominent technique for the ionization of biomolecules 
is matrix-assisted laser desorption/ionization (MALDI) that uses laser energy absorbing 
reagents in order to create stable ions from large molecules. The created ion’s 
m/z-values are commonly determined by time-of-flight mass spectrometry (TOF-MS) 
or Fourier transform ion cyclotron resonance mass spectrometry (FTICR-MS) that 
provides substantially improved mass resolving power for ultrahigh-resolution MS.  
 
1.3.1 History of mass spectrometry 
The technique was first presented in the early 1910s by Joseph John Thomson and 
Francis William Aston [66, 67] who discovered the existence of isotopes by means of 
elemental MS. In 1919, Aston also constructed the first velocity focusing mass 
spectrometer with a resolving power of 130 [68]. Due to the high energy ionization, 
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initial MS experiments were restricted to elemental and small molecule analyses until 
the development of soft ionization techniques. First attempts to enhance the detectable 
mass range were reported by William Stephens in 1946 who demonstrated pulsed 
ionization which formed the basis for the development of TOF-MS in 1948 [69, 70]. 
Decades later, in 1974, FTICR-MS with superior mass resolution was demonstrated 
by Melvin Comisarow [71]. However, a major breakthrough for the analysis of larger 
molecules was the development of chemical ionization in the 1960s [72]. Thereby, 
ionization was achieved by means of ion-transfer reactions of a sample’s molecules 
and reagent ions. This less energetic procedure was proven to reduce fragmentation 
and resulted in more stable ions when compared to electron ionization methods. To 
date, the most frequently used soft ionization technique used for the analysis of 
biomolecules (i.e. proteins, peptides, lipids, sugars) is MALDI, which was first reported 
by Franz Hillenkamp and Michael Karas in 1985 [73, 74]. By using tryptophan for 
ionization and a pulsed 266nm laser they demonstrated the ionization of peptide 
molecules up to 2843 Da. Desorption ionization of larger molecules (up to 34472 Da) 
by combining 30 nm cobalt particles in glycerol and a 337nm nitrogen laser was 
reported by Koichi Tanaka in 1987 [75]. The low cost of 337nm nitrogen lasers led to 
the first commercially available MALDI-MS instruments in the early 1990s. Nowadays, 
355nm neodymium-doped yttrium aluminium garnet (Nd:YAG) laser are commonly 
used.  
 
1.3.2 Basic principles of mass spectrometry used in biomedical science 
A mass spectrometry experiment can be divided into two major steps for which multiple 
techniques exist. Firstly, the elements or molecules of interest are ionized. Secondly, 
the generated ions are separated based on their m/z-value and the intensity pattern is 
measured. In biomedical science, MALDI is the most commonly used ionization 
techniques to date. During MALDI-MS, a layer of matrix solution that typically consists 
of a small organic acid is either applied onto a tissue or mixed with extracted cells. The 
matrix incorporates the sample’s analytes into matrix crystals formed upon solvent 
evaporation. Molecular ions are then generated upon radiation by a pulsed and 
focused laser aimed at the sample surface (Fig. 4).  
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Figure 4 Schematic illustration of MALDI-MS soft ionization.  Samples are 
mounted on conductive slides and matrix is applied across the specimen to 
incorporate analytes into crystals. Upon radiation by a pulsed laser beam, molecular 
ions are generated by means of ion-transfer reactions between analyte and matrix. 
Mass spectra are generated by separating the ions based on their m/z-value. 
 
The precise and standardized application of matrix is of crucial importance to ensure 
optimal extraction and to avoid diffusion and delocalization effects [76]. Moreover, the 
choice of matrix is of importance, as several different matrixes allow for an array of 
biomolecular classes to be analyzed [77]. For example, super-2,5-dihydrobenzoic acid 
(sDHB), a mixture that consists of 2,5-Dihydrobenzoic Acid (DHB) and 
2-Hydroxy-5-Methodybenzoic Acid is highly effective for the analysis of proteins, 
whereas 4-Phenyl-α-Cyanocinnamic acid amide (PhCCA) is better suited to analyze 
(negatively) charged peptides [78]. In order to avoid potential artifacts that may arise 
due to matrix application, it is important to apply the substance homogeneously [79]. 
For the reproducible production of analyte-ion signals, automated application systems 
that spray-coat or sublime matrix are often utilized in modern MALDI-MSI. Apart from 
MALDI, alternative ionization techniques like desorption electrospray ionization (DESI) 
and rapid evaporative ionization mass spectrometry (REIMS) have recently shown 
their potential to classify clinical tissues [80, 81]. DESI enables ambient ion generation 
by employing a fast-moving charged solvent stream onto the sample surface. After 
ionization, the ions travel through air into an atmospheric pressure interface that is 
connected to a mass spectrometer. In contrast, REIMS is a unique technique that can 
be utilized intra-operatively. A specialized tissue-cutting tool (i.e. a surgical laser) leads 
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to the formation of an aerosol that contains tissue-specific ionized cell constructs. This 
flue gas is then analyzed by means of mass spectrometry. However, MALDI-MSI is to 
date the most popular method for clinical applications [82].  
 
Just like with the generation of ions, a multitude of techniques to disaggregate and 
determine the ion’s m/z ratio are available. Commonly used techniques are TOF-MS 
and FTICR-MS for ultrahigh-resolution MS. In TOF-MS, ions are accelerated by an 
electric field of known strength and directed through an evacuated flight tube. Velocity 
and consequently drift time t of every ion depends on its m/z ratio (t2 ~ m/z), as heavier 
ions are slower than lighter ions and a higher charge results in increased velocity. Mass 
resolution and accuracy in TOF-MS can be improved by an ion mirror (reflectron) at 
the opposing end of the flight tube that reverts the ions travel direction (Fig. 5A). 
Thereby, the spread in kinetic energy of ions with the same m/z at the exit from the ion 
source gets corrected [83]. The separated masses of ions in the reflectron can range 
from a few Daltons to a few million Daltons.  
 
In FTICR, the m/z of an ion is determined based on its cyclotron frequency in a fixed 
magnetic field. Generated ions are retained in a magnetic field with electric trapping 
plates (Penning trap) where they are excited by an oscillating electric field orthogonal 
to the magnetic field. After excitation, the ions rotate at their cyclotron frequency and 
induce a charge when passing a pair of electrodes (Fig. 5B). The resulting 
interferogram can be converted to give a mass spectrum by means of Fourier transform 
calculation.  
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Figure 5 Schematic outline of a time-of-flight (TOF) and Fourier transform ion cyclotron 
resonance (FTICR) mass analyzer.  (A) During a MALDI-TOF-MS measurement, the 
molecules of the examined sample are ionized, vaporized and directed through an evacuated 
flight tube. Ions are accelerated by an electric field depending on their m/z-value. Low mass 
molecules reach the detector in a shorter time than heavier ones and are thus separated. A 
reflectron may correct the spread in kinetic energy of ions with the same m/z to improve mass 
resolution and accuracy for smaller molecules. (B) During a FTICR-MS measurement, the 
generated ions enter a Penning trap in which they are excited at their resonant cyclotron 
frequencies orthogonal to the magnetic field. Each ion cycles at characteristic radius and 
frequency and induces an electric signal as it passes the detection plates. The resulting signal 
is converted to a time-domain frequency spectrum that converts into a mass spectrum by 
Fourier transform. 
 
1.3.3 Mass spectrometry imaging 
Mass spectrometry imaging (MSI) is an ex vivo imaging technology that extends 
conventional MS with a screening process. It enables the assessment of molecular 
information in a spatially resolved area and was first described by Helmut Liebl in 
1967 [84]. The first imaging experiments that utilized MALDI were performed by 
Richard Caprioli in the late 1990s [85]. In a spatially resolved screening process, ions 
are created at any given (x/y)-coordinate of a matrix-coated specimen placed on a 
conductive object carrier (i.e. organ or biopsy sections) by applying laser radiation. 
Thereby, the precise and standardized preparation of tissue sections as well as a 
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homogeneous application of matrix substance are of crucial importance. Subsequently 
to ion production, a spectrum containing the abundance of molecules within a given 
m/z-range is recorded. The entirety of recorded spectra is used to construct a 
hyperspectral map in which the prevalence of each acquired m/z-value can be 
translated into a false-color distribution image (Fig. 6).  
 
 
Figure 6 Principle of MALDI-MSI  In a screening process, mass spectra are recorded after laser 
irradiation in a grid-like manner for multiple (x,y)-coordinates. At each spot, m/z-values of abundant 
ions are recorded and stored within a given range. The prevalence of each m/z can be presented 
as a false-color distribution map and registered to the tissue’s histology. (Figure source [86]). 
 
1.3.4 Diagnostic and pharmacological applications of MSI 
The ability of MSI to localize chemical compounds like pharmaceuticals as well as 
uncover disease-related biomolecular changes has led to a rapid and substantial 
impact on clinical and pharmacological research (reviewed in [87]). In comparison to 
conventional in vivo imaging techniques and stains, MSI provides unparalleled 
label-free chemical insight into the distribution pattern of hundreds of biomolecules. 
Several key studies have demonstrated its ability to uncover disease-related 
biomolecular shifts, even if highly localized or invisible to established histopathology. 
For this reason, one of the most prevalent applications for MSI is the identification and 
localization of disease-associated biomarker profiles that have been demonstrated to 
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complement classical histopathology (reviewed in [88]). In addition, MSI also plays a 
vital role in drug discovery as it provides imaging of pharmaceuticals and their 
metabolites in two-dimensional sections [89] and 3D tissue models that combine 
multiple subsequently acquired images [90]. In recent publications, MALDI-MSI-
derived mass profiles were used to distinguish between transformed cells in formalin-
fixed paraffin-embedded (FFPE) and fresh frozen cancer tissues [91, 92]. Moreover, 
marker proteins identified by means of MALDI-MSI were used to predict survival rates 
in gastric cancer [93] as well as therapy response in breast cancer [94] and esophageal 
carcinoma [95]. These studies reflect the high potential of MALDI-MSI in identifying 
and visualizing transformed cells in tissues as well as the molecular changes linked to 
their aberration [96]. However, cell heterogeneity impedes the identification of true 
molecular biomarkers, as it becomes uncertain which mass signature belongs to which 
subpopulation. For this, the prior selection of “pure” cell groups of similar molecular 
makeup is necessary, which emphasizes the need for prior histological specification. 
In this regard, the ability to apply tissue staining after MSI acquisition [97] without the 
loss of histopathological features has fueled the integration of MSI and classical 
histology [21, 98]. However, particular limitations still impede the applicability of 
MALDI-MSI in clinical practice, as the acquisition time needed per section makes 
especially ultrahigh-resolution MSI impractical for the analysis of larger tissue cohorts. 
The high amount of created data and the lack of standardized workflow represents 
additional challenges. In order to contradict these limitations, first attempts to utilize 
guiding modalities like FTIR or polarimetry that provide fast in-depth characterization 
of a tissue’s structural composition were recently reported [18, 20]. 
 
1.4 Neuronal disorders and cancer  
MSI experiments provide spectral information that further elucidates the molecular 
shifts that differentiate between tissue types in different disease states. It has therefore 
been the analytical technique of choice to distinguish between alternated cell 
populations and retrieve potential biomarkers in many cancer studies [99, 100]. Cancer 
remains the major cause of death in economically developed countries. In 2015, a 
study [101] reported that in 2012 about 14.1 million new cases occurred worldwide and 
8.2 million deaths were caused by the disease. Two cancer types of particular interest, 
namely gastrointestinal stromal tumors (GIST) and glioblastoma, will be described in 
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greater detail. Apart from cancer, MALDI-MSI’s capabilities to spatially resolve the 
distribution of proteins, metabolites, lipids, peptides and pharmaceuticals have made 
the technique especially useful to examine structural organs. In this sense, MSI has 
extensively been used to investigate biomolecular shifts in neurological disorders. The 
potential to differentiate between biomolecule species makes it especially useful for 
the examination of brain lipid accumulations caused by lysosomal storage diseases, 
i.e. Niemann-Pick type C.  
 
1.4.1 Gastrointestinal stromal tumors 
Among the various phenotypes of cancer, sarcoma that arise from transformed cells 
of mesenchymal origin are quite rare and account for less than 1% of all adult solid 
malignant tumors [102]. About 90% of diagnosed sarcomas are soft tissue sarcomas, 
among which gastrointestinal stromal tumors are the most common. Unlike most 
gastrointestinal tumors, GIST arises from connective tissue instead of epithelial tissue. 
The aberrant cells typically originate from the stomach (70%), but can later on 
disseminate to the liver, omentum and peritoneal cavity. GIST is thought to arise from 
dispersed interstitial Cajal-like cells that have the potential for bidirectional 
differentiation towards neural lines and myoid cells. In most cases, the cellular 
aberration is driven by a mutation of the KIT or PDGFRα gene (80-90%), but wild-types 
that feature multiple or deviating mutations have also been reported [103]. For this 
reason, the genetic characterization of GIST is important as it denotes the 
effectiveness of targeted drug therapies. In cases for which resection is anatomically 
and physiologically feasible, complete surgical excision of the localized tumor region 
is the treatment of choice [104]. For the treatment of metastatic and unresectable GIST, 
Imatinib (Gleevec®) and other tyrosine kinase inhibitors (Sunitinib, Regorafenib) are 
approved by the United States Food and Drug Administration (U.S. FDA) [105]. 
Imatinib inhibits, among other targets, c-KIT and PDGFR tyrosine kinase activity by 
binding close to its ATP binding site, thus locking it in a closed or self-inhibited 
conformation and ultimately inducing cell death. Although Imatinib also binds to non-
cancer cells, these cells typically possess additional redundant tyrosine kinases that 
secure their function. Imatinib is also considered for adjuvant treatment in order to 
minimize the risk of tumor resurgence. However, the drug’s efficacy highly depends on 
the respective genotype, as multiple forms of c-KIT- and PDGFRα- mutation-negative 
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GIST as well as the PDGFRα D842V mutant subtype are considered to be 
Imatinib-resistant.  
 
1.4.2 Glioblastoma multiforme 
Glioblastoma multiforme is the most common and aggressive primary brain cancer 
found in humans. It is usually rapidly fatal, with a short median overall survival rate of 
15 months only [106], although in 3-5% of cases, long-term survival that exceeds three 
years has been reported [107]. The cellular origin of glioblastoma is unknown, but most 
likely includes glial type cells, astrocytes, oligodendrocytes progenitor cells and neural 
stem cells [108]. In contrast to other astrocytoma grades, glioblastoma multiforme is 
characterized by the presence of necrotic lesions that are surrounded by anaplastic 
cells and hyperplastic blood vessels. For diagnosis, a combination of CT, MRI and 
tissue biopsy taking is typically utilized. The standard treatment, if feasible, is gross 
resection, followed by radiotherapy and administration of Temozolamide, a 
chemotherapy drug [109]. Temozolamide is an alkylating agent that is toxic to cancer 
cells due to inhibition of tumor cell DNA replication. Alkylation typically occurs at the N-
7 or O-6 position of DNA guanine residues.  
 
1.4.3 Niemann-Pick disease, type C 
The group of Niemann-Pick diseases includes multiple severe metabolic disorders that 
result in sphingomyelin accumulation. Unlike type A and B, for which the cause of 
disease is complete or partial enzymatic deficiency of acid sphingomyelinase, type C 
disease is associated with mutations in the NPC1 and/or NPC2 gene that encode 
endosomal-lysosomal transporter proteins. The mutations lead to impaired intracellular 
lipid trafficking and accumulation of unesterified cholesterol and glycosphingolipids in 
the brain and other tissues [110]. The age at onset may vary from the perinatal period 
(< 3 months) to adult age. The disease has manifold symptoms, including liver and 
spleen enlargement as well as a variety of neurological disorders, such as epilepsy, 
cerebellar ataxia, dysarthria, dysphagia, spasticity, psychosis and progressive 
dementia. To date, treatment options are limited and no known cure exists. Since 
glycolipid storage appears to contribute to the neuropathological features of the 
disease [111], Miglustat (Zavesca®), an iminosugar inhibitor, has been approved in 
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Europe, Japan and Canada for treating progressive neurological complications in 
patients that suffer from Niemann-Pick disease, type C. Miglustat is a glucose-
analogue that irreversibly inhibits the activity of the glycosylceramide synthase 
enzyme, thus reducing the production and accumulation of glycosylceramide in cells. 
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2 AIMS 
MSI, encompassing all modes and methods can bring informative in-depth molecular 
insight into the pathology and chemical biology of (pre)clinical tissue samples. The 
implementation of MSI into the (pre)clinical setting holds great promise in the 
enhancement of personalized medicine and biomarker detection. However, key 
limitations of MALDI-MSI are sample throughput, data load, the availability of 
validated/standardized technical routine’s and the integration with conventional 
pathology or other medical imaging techniques. The analysis of large tissue series is 
impractical, as established approaches acquire MSI data of whole tissue sections prior 
to histopathological annotation. In contrast, optical imaging techniques like vibrational 
spectroscopy can assess the structural composition of tissues with relative ease, but 
lack the chemical specificity needed for biomarker retrieval. A multimodality approach 
that combines both technologies capabilities might have substantial impact on clinical 
practice.  
 
For this reason, the study at hand focused on the following objectives:  
 
1) Determination of each modality’s capabilities to segment and classify divergent 
cell populations. In this context, the influence of different slide-coating materials 
was investigated.  
 
2) Development and technical evaluation of an automated and robust workflow 
that enables combined, multimodal imaging of tissues using FTIR and 
MALDI-MS imaging techniques.  
 
3) Evaluation of the routine’s capability to correctly distinguish between normal and 
diseased cell populations in tissues. For this task, various mouse models as 
well as human cancer tissues were examined.  
 
4) Evaluation of the routine’s capability to enable unbiased targeting for 
MALDI-FTICR-MS, thus addressing computational and practical challenges that 
restrict the transition of ultrahigh-resolution MS to clinical practice.  
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3 DATA ANALYSIS BACKGROUND  
Extracting significant features out of complex data sets is a major challenge in 
biomedical imaging. In that regard, the high dimensionality of i.e. FTIR and particularly 
MS images introduces profound restrictions. Apart from introducing practical and 
computational limitations regarding data processing, the concept of distance between 
data points becomes very imprecise as dimensionality grows [112]. This problem 
referred to as the “Curse of Dimensionality” degrades the predictive power of 
classification models and the efficacy of segmentation. Multimodality imaging 
introduces additional challenges as joint interpretation and visualization are impossible 
without alignment of all images into a common coordinate system. In this section, 
multivariate statistical tools that tackle the challenges associated with multimodality 
imaging and high dimensionality will be examined. Moreover, methods that extract 
spatial and spectral features will be demonstrated.  
 
3.1 Dimensionality reduction 
Collection of FTIR and MS spectra results in high-dimensional data, with FTICR 
spectra typically featuring intensities of around one million m/z-values. This introduces 
some practical and computational restrictions, as the produced image size becomes 
very large and the computation time to process the data is drastically increased [113]. 
Especially for MSI, the collected data is very sparse and contains many dimensions 
more than it contains information. Dimensionality reduction aims to project the data 
onto a smaller subspace that preserves its information by combining redundant 
measures and discarding unsubstantial dimensions. Prominent examples of 
dimensionality reduction tools are principal component analysis (PCA) and t-distributed 
stochastic neighbor embedding (t-SNE) [114, 115].  
 
3.1.1 Principal Component Analysis 
PCA is a widespread factorization method that reduces dimensionality while retaining 
most of the data variance. The algorithm reorients the original data onto a new space 
that is defined by a number of orthogonal axes (principal components) equivalent to 
the original data’s dimensionality. The principal components are sorted in descending 
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order by the amount of variance they preserve. For that reason, the first few principal 
components (PC) describe the majority of data variance, thus dimensionality reduction 
can be achieved by discarding later components (Fig. 7). Typically, the subset of 
retained PCs is chosen so that at least 95% of the original data’s variance are 
preserved. 
 
 
Figure 7 Dimensionality reductions by means of principal component analysis.  A reduced two-
dimensional component space is defined by the first two principal components (PC1, PC2) and used for 
transformation of the whole data set (red and green data points). Thereby, the PCs preserve the original data 
variance in descending order. Transformation of data into a smaller component space allows for dimensionality 
reduction while preserving most of the original data’s variance. 
 
PCs can be located through singular value decomposition (1) in which the mean 
centered data ?̃? gives [116]:.  
 
?̃? = 𝑈𝛴𝑊𝑇  (1) 
 
where 𝛴 is an n-by-p diagonal matrix of the singular values of ?̃?, U is an n-by-n matrix 
of orthogonal unit vectors of length n (the left singular vectors of ?̃?) and W is a 
p-by-p matrix of orthogonal unit vectors of length p (the right singular vectors of ?̃?). The 
right singular vectors W are equivalent to the eigenvectors of 𝑋𝑇𝑋, while the singular 
values of 𝛴 are equal to the square roots of the eigenvalues λ. Using singular value 
decomposition, the new projection of data TL (called scores) that considers only the 
first L largest singular values and their singular vectors is given by (2): 
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𝑇𝐿 = 𝑈𝐿𝛴𝐿 = ?̃?𝑊𝐿  (2) 
 
3.1.2 t-distributed stochastic neighbor embedding 
PCA is a linear dimensionality reduction technique and thus highlights the major 
variance while minimizing subtle changes. For this reason, the similarities of 
highly-dimensional data can often not be faithfully represented. Recently emerging 
nonlinear methods like t-SNE have proven their capability to preserve local detail and 
global data structure in life-science applications by emphasizing similarities between 
data points [117, 118]. The algorithm starts by calculating the distance d(xi,xj) between 
each pair of data points xi and xj of the input data X consisting of N objects. Different 
metrics can be applied for distance calculation, i. e. Euclidean metric (3) that defines 
d(xi,xj) as follows: 
 
𝑑(𝑥𝑖 , 𝑥𝑗) = √∑ (𝑥𝑖,𝑘 − 𝑥𝑗,𝑘)2
𝑛
𝑘=1
 (3) 
 
Then, t-SNE constructs a probability distribution over pairs of xi and xj in terms of a 
Gaussian distribution, so that similar objects have a high conditional probability p j/i (4) 
of being picked as neighbors, whereas this probability to pick dissimilar points is 
extremely small.  
 
 
𝑝𝑗/𝑖 =
exp (−𝑑(𝑥𝑖 , 𝑥𝑗)
2
/(2𝜎𝑖
2))
∑ exp⁡(𝑘≠𝑖 − 𝑑(𝑥𝑖 , 𝑥𝑘)2/(2𝜎𝑖
2))
 
𝑝𝑖/𝑖 = 0 
(4) 
 
Based on this probability, t-SNE then aims to learn a d-dimensional map that reflects 
the joint probability pij (5) as precise as possible.  
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𝑝𝑖𝑗 =
𝑝𝑗/𝑖 + 𝑝𝑖/𝑗
2𝑁
 (5) 
 
This minimization procedure begins with an initial set Y of random Gaussian-distributed 
points for which the probability model qij of the distribution of the distances between 
points yi and yj is calculated (6).  
 
 
𝑞𝑖𝑗 =
(1 + ‖𝑦𝑖 − 𝑦𝑗‖
2
)
−1
∑ ∑ (1 + ‖𝑦𝑘 − 𝑦𝑙‖2)−1𝑙≠𝑘𝑘
 
𝑞𝑖𝑖 = 0 
(6) 
 
This initial model is then iteratively updated to minimize the Kullback-Leibler 
divergence KL(P\\Q) between a Gaussian distribution in the high-dimensional space P 
and a t-distribution in the low-dimensional space Q [119]. For optimization, the 
algorithm uses a modified gradient descent procedure to reach a good local 
minimum (7). 
 
𝐾𝐿(𝑃\\𝑄) = ∑∑𝑝𝑖𝑗 ⁡𝑙𝑜𝑔
𝑝𝑖𝑗
𝑞𝑖𝑗
𝑖≠𝑗𝑗
 
(7) 
 
3.2 Information extraction 
Common biomedical experiments focus either on the identification of discriminatory 
features used to differentiate between disease states, or segmentation of the image 
into sub-regions of spectral similarity used for exploratory analysis [120]. In that 
context, information extraction aims to present the user with spectra or images that 
represent important features of the data.  
 
3.2.1 k-means++ segmentation 
The k-means++ algorithm aims to partition the data into k subgroups of greatest 
internal similarity [121]. Based on a specific similarity measure, for example the L1-
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distance which is more suitable in high-dimensional space and defines the distance 
between two p-dimensional observations (i.e. spectra) x and y as follows (8), each 
spectrum is assigned to the closest of k centroids. 
 
𝑑(𝑥, 𝑦) =∑|𝑥𝑖 − 𝑦𝑖|
𝑝
𝑖=1
 (8) 
 
In contrast to the classic k-means approach (Lloyd’s algorithm) in which k initial 
centroids are placed randomly within the data space and assignment of spectra is 
achieved in an iterative refinement loop [122], k-means++ uses a heuristic process to 
improve run time and classification efficacy [121]. Thereby, a random observation of 
the data set X is chosen as the first centroid c1 and the distances d(Xm,c1) of all other 
observations m ∈ n are computed. Thereafter, the next centroid c2 is selected at 
random with probability defined as follows (9).  
 
𝑑2(𝑋𝑚 , 𝑐1)
∑ 𝑑2(𝑋𝑗 , 𝑐1)
𝑛
𝑗=1
 (9) 
 
Center j is chosen by computing the distances from each observation to each centroid 
and subsequent assignment of each observation to its closest centroid. Then, for 
m = 1,…,n and q = 1,…,j-1, the next centroid j is selected at random with probability 
defined as follows (10), with ?̇?𝑝 being the set of all observations closest to the centroid 
cp and Xm belonging to ?̇?𝑝. 
 
𝑑2(𝑋𝑚, 𝑐𝑝)
∑ 𝑑2(𝑋ℎ , 𝑐𝑝){ℎ;𝑋ℎ∈?̇?𝑝}
 (10) 
 
Distance calculation, assignment and centroid selection are repeated until k centroids 
are chosen. For segmentation purposes, it is possible to color-code each pixel of an 
image based on its allocation to a given centroid. 
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3.2.2 Feature extraction 
MS and FTIR spectra, though rich in biomolecular information contain high levels of 
redundancy, as many acquired m/z and cm-1 intensities either mitigate from correlated 
sources (i.e. isotopic peaks in MS) or refer to signal-free noise. By extracting 
informative features (i.e. peaks in MS or wavenumber ranges in FTIR) and discarding 
the rest, a dataset’s size and complexity can be reduced substantially [123]. Feature 
extraction can also be applied to screen for an optimal sub-feature space that better 
represents the differences between a pre-defined training set. A suitable technique for 
the selection of discriminatory features with respect to tissue classification is the 
receiver operating characteristic curve (ROC) criterion [124]. Thereby, the overlap 
between the probability distance functions describing each feature’s data distribution 
in two classes is calculated as a measure of discriminatory power. For complete 
overlap the area under the ROC curve (AUC) and the random classifier slope equals 
zero, whereas an AUC = 0.5 indicates complete separation. The monitored m/z- and 
cm-1-values obtained from tissues of different morphological makeup are then sorted 
in descending order based on their AUC.  
 
3.3 Quality measures 
Dimensionality reduction and information extraction techniques aim to present 
manageable and substantial data by reducing redundancy and noise. In order to 
evaluate the quality of the obtained results several techniques exist.  
3.3.1 Cluster evaluation 
The number of clusters (k) assumed during k-means++ segmentation is a freely 
chosen input parameter and a major drawback to the technique, as inappropriate 
k-values may yield poor results. For this reason, several criteria that serve as a 
diagnostic check in order to determine the number of anticipated groups in a data set 
consisting of N observations exist. One of the most common cluster evaluation criteria 
is the Calinski-Harabasz index published in 1974 [125]. For a given value of k, the 
Calinski-Harabasz criterion CHc is a measure of the between-cluster variance SSB to 
within-cluster variance SSW ratio (11).  
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𝐶𝐻𝑐 =
𝑆𝑆𝐵
𝑆𝑆𝑊
×
(𝑁 − 𝑘)
(𝑘 − 1)
 (11) 
 
Thereby, the overall between-cluster variance SSB is defined as follows (12), with m 
being the mean of all sample data, mi being the centroid of cluster i, and ||mi-m|| being 
the L2 norm between both vectors.  
 
𝑆𝑆𝐵 = ∑𝑛𝑖‖𝑚𝑖 −𝑚‖
2
𝑘
𝑖=1
 (12) 
 
In contrast, the overall within-cluster variance is defined as follows (13), with x being a 
data point, ci being the i-th cluster and ||x-mi|| being the L2 norm between the two 
vectors.  
 
𝑆𝑆𝑊 =∑∑‖𝑥 −𝑚𝑖‖
2
𝑥∈𝑐𝑖
𝑘
𝑖=1
 (13) 
 
Well-defined clusters have a large between-cluster variance and a small within-cluster 
variance, so a larger CHc resembles better data partition. In order to determine the 
optimal number of clusters k, the Calinski-Harabasz index can be calculated for 
multiple k-values. The highest computed CHc is then assumed to correspond to the 
optimal number of clusters.  
 
3.3.2 Measure of data dispersion  
Several measures can be applied in order to assess the consistency of 
dimensionality-reduced spectra of similar origin. In that regard, the mean absolute 
deviation (MAD) is a suitable technique to evaluate stability and technical 
reproducibility [126]. The MAD of a data set X consisting of x1, x2, …, xn is defined as 
follows (14):  
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1
𝑛
∑|𝑥𝑖 − ?̅?|
𝑛
𝑖=1
 (14) 
 
Thereby, ?̅? denotes the mean of x. In terms of technical reproducibility, the calculated 
MAD-value should be as small as possible, as a high value indicates considerable data 
dispersion. 
 
3.3.3 Sample correlation and dependence 
One of the most common measures to determine similarity in scientific research is the 
sample Pearson correlation coefficient R, which expresses the degree of linear 
correlation between observations as a value between -1 and +1. Thereby, +1 and -1 
refer to a total positive or negative correlation, whereas R = 0 refers to no linear 
correlation. The sample correlation coefficient was developed by Karl Pearson in 1985 
and determines the dependence between two series of n observations X and Y [127], 
where X consists of x1, x2, …, xn and Y consists of y1, y2, …, yn, as follows (15):  
 
1
𝑛 − 1
∑(
𝑥𝑖 − ?̅?
𝜎𝑥
)
𝑛
𝑖=1
(
𝑦𝑖 − ?̅?
𝜎𝑦
) (15) 
 
Thereby, ?̅? and 𝜎𝑥 denote the mean and standard deviation of X, and ?̅? and 𝜎𝑦 denote 
the mean and standard deviation of Y.  
 
3.4 Image registration and evaluation 
Image registration is an indispensable tool for the integration of multimodality data sets, 
especially in medical and biological applications [128, 129]. The process aims to 
spatially align two or more images of the same object. Typically, one image is defined 
to be fixed and serves as a reference If to align the other moving image/images Im. In 
an optimization process, the moving image is then geometrically transformed to be 
spatially aligned with the fixed image. The optimized transformation parameters μ are 
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calculated according to the standard registration optimization problem (16), in which 
the cost function C is minimized with respect to the transformation model T. 
 
?̂? = argmin
𝜇
𝐶[𝐼𝑓 , 𝑇(𝐼𝑚)] (16) 
 
The accuracy of transformation can be evaluated by calculating the Dice similarity 
coefficient (DSC) [130]. The DSC defines similarity as the intersection |𝑋 ∩ 𝑌| between 
Im and If divided by the numbers of elements (pixels) |𝐼𝑚| and |𝐼𝑓| in the two 
images (17). If DSC = 1, a perfect match between transformed and fixed image could 
be achieved, whereas DSC = 0 indicates two completely separated images.  
 
𝐷𝑆𝐶 =
2|𝐼𝑚 ∩ 𝐼𝑓|
|𝐼𝑚| + |𝐼𝑓|
 (17) 
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4 MATERIALS AND METHODS 
4.1 Materials  
4.1.1 Reagents 
NAME CATALOGUE COMPANY LOCATION 
Acetic Acid 6755.2 Merck Darmstadt, GER 
Acetone 20067.320 VWR Intern. Darmstadt, GER 
Acetonitrile 83640.320 VWR Intern. Darmstadt, GER 
Carboxymethyl Cellulose 6190.1 Carl Roth Gmbh 
+ Co. KG 
Karlsruhe, GER 
Chloroform 83626.320 VWR Intern.  Darmstadt, GER 
2,5-Dihydroxybenzoic Acid 8201346 Bruker Daltonics Bremen, GER 
Ethanole absolute 8.18760.2500 AppliChem Darmstadt, GER 
Eosin Y X883.2 Merck Darmstadt, GER 
Hematoxylin 1.09249.2500 Merck Darmstadt, GER 
n-Hexane 83991.320 VWR Intern.  Darmstadt, GER 
Magnesium sulfate A4837.1000 AppliChem Darmstadt, GER 
Methanol 83638.320 VWR Intern.  Darmstadt, GER 
4-Phenyl-α-Cyanocinnamic 
Acid Amide 
SC-1400 SiChem Bremen, GER 
sDHB MALDI Matrix 
(Mixture of 
2,5-Dihydrobenzoic Acid 
and 2-Hydroxy- 
5-Methodybenzoic Acid 
8209813 Bruker Daltonics Bremen, GER 
Sodium hydrogen 
carbonate 
1.06392.0500 Merck  Darmstadt, GER 
Trifluoroacetic Acid  1082620100 Merck Darmstadt, GER 
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4.1.2 Solutions  
 
NAME COMPOSITION 
Blueing Solution  2 g NaHCO3 
20 g MgSO4 
Add to 1 L with ddH2O 
Carnoy’s Fluid 60 mL EtOH 
30 mL CHCl3 
10 mL CH3COOH 
 
4.1.3 Consumables 
NAME COMPANY LOCATION 
Centrifuge Tubes  
0.5/1/2 mL 
Eppendorf Hamburg, GER 
Centrifuge Tubes  
15/50 mL 
VWR Intern.  Darmstadt, GER 
Gold-coated Slides Science Services München, GER 
MALDI ITO glass slides Bruker Daltonics Bremen, GER 
MirrIR slides Kevley Technologies Chesterland, USA 
Nitril examination gloves VWR Intern.  Darmstadt, GER 
Peptide calibration standard II  Bruker Daltonics Bremen, GER 
Pipet Tips  
10/200/1000 μL 
VWR Intern.  Darmstadt, GER 
Protein calibration standard I Bruker Daltonics Bremen, GER 
Starfrost adhesive slides R. Langenbrinck GmbH Emmendingen, 
GER 
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4.1.4 Equipment 
NAME COMPANY LOCATION 
Aperio CS2 Digital Pathology 
Slide Scanner 
Leica Biosystems Nussloch, GER 
Autoflex Speed MALDI-
TOF/TOF Mass Spectrometer 
Bruker Daltonics Bremen, GER 
CanoScan 9000F Mark II 
optical scanner 
Canon Deutschland GmbH Stuttgart, GER 
Cryostat Leica CM 1950 Leica Biosystems Nussloch, GER 
NalgeneTM Polycarbonate 
Desiccator 
Thermo Fisher Scientific Darmstadt, GER 
Frontier MIR system Perkin Elmer Germany Rodgau, GER 
Matrix application device Sun 
Collect 
SunChrom Friedrichsdorf, GER 
solariX XR 7T MALDI-FTICR 
Mass Spectrometer 
Bruker Daltonics Bremen, GER 
Sonic Bath VWR Intern Darmstadt, GER 
Spotlight 400 Infrared 
Microscope 
Perkin Elmer Germany Rodgau, GER 
Ultraflex MALDI-TOF/TOF 
Mass Spectrometer 
Bruker Daltonics Bremen, GER 
Vacuum Pump N726 FT.18 KNF Neuberger GmbH Freibug im 
Breisgau, GER 
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4.1.5 Software 
Adobe Photoshop CS6 Adobe San José, USA 
flexControl Bruker Daltonics Bremen, GER 
flexImaging 4.1 Bruker Daltonics Bremen, GER 
MATLAB R2017a The Mathworks Natick, USA 
R R Core Team 
(https://www.r-project.org) 
Vienna, Austria 
Tableau Tableau Software Inc. Seattle, USA 
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4.2 Methods 
4.2.1 Animal studies  
Animal studies on engrafted CD1 nu/nu mice were conducted at the German Cancer 
Research Center (DKFZ, Heidelberg) and supervised by institutional animal protection 
officials in accordance with the National Institute of Health’s guidelines Guide for the 
Care and Use of Laboratory Animals. The experiments were approved by 
governmental authorities (Regierungspräsidium Karlsruhe, Germany). Female 
6-12 week old mice were inoculated with 105 human U87-MG glioblastoma cells and 
sacrificed when the first mouse became symptomatic (5-6 weeks after inoculation). In 
addition, C57BL/6 mouse brain samples were provided for reference purposes. 
 
Brain samples of Niemann-Pick-C1 I1061T knock-in-mice and C57BL/6 control mice 
were provided by the Ory laboratory at Washington University in St. Louis, USA [131]. 
Animals were kept in a controlled animal facility and given standard chow and water 
ad libitum. Weaning occurred after 3-4 weeks. Experimental procedures were 
approved by the Washington University Animal Studies Committees and were 
conducted in accordance with the USDA Animal Welfare Act and the Public Health 
Service Policy for the Human Care and Use of Laboratory Animals.  
 
All provided animal organs and xenograft tissues were excised and immediately snap-
frozen in liquid nitrogen. Until further processing, samples were stored in a freezer 
at -80 °C.  
 
4.2.2 Human tissue specimen 
Patient-derived GIST and prostate cancer samples for the analysis of mid-infrared 
(MIR) and mass signatures were provided by the University Medical Centre Mannheim. 
Informed consent was obtained in all cases from patients whose tissues were used in 
this dissertation. FTIR and MS acquisition were performed in accordance with 
applicable laws and regulations, good clinical practices and approved by an 
independent ethics committee of Heidelberg University (“Medizinische Ethik-
Kommision II”; No. 2012-293N-MA).  
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4.2.3 Tissue section preparation  
Frozen organs and tissue specimen were cut using a CM1950 cryostat (Leica 
Biosystems, Nussloch). For all experiments, the cryostat chamber temperature was 
set to -20°C. First of all, the samples were mounted onto a cryostat metal plate by 
applying a drop of 2% (w/v) carboxymethyl cellulose (Merck, Darmstadt). 
Subsequently, the tissue was cut into sections of 8 μm thickness for an improved 
permeation of mid-infrared raditation [49]. Tissue slides designated for multimodal 
measurements on single sections were placed on gold-coated slides (Science 
Services, München). Sections designated for exclusive MALDI-MSI were mounted on 
indium tin oxide (ITO)-coated glass slides (Bruker Daltonics, Bremen). Sections 
designated for exclusive FTIR measurements were mounted on MirrIR object slides 
(Kevley Technologies, Chesterland). Sections prepared for pathological examination 
and annotation at the Pathology Institute of the University Medical Center Mannheim 
(UMM) were placed on Starfrost adhesive microscope slides (R. Langenbrinck GmbH, 
Emmendingen). After cutting, all slides were dried at room temperature (RT) in a 
NalgeneTM Polycarbonate Desiccator (Thermo Fisher Scientific, Darmstadt) connected 
to a vacuum pump N726 FT.18 (KNF Neuberger GmbH, Freiburg im Breisgau) for at 
least 3h. The samples were either measured immediately or stored at -80°C for later 
image acquisition.  
 
For protein MSI, a multi-step washing protocol was carried out on ice to minimize lipid 
interferences [132]. The protocol comprises the application of (1) 70% ethanol (EtOH; 
AppliChem, Darmstadt) for 30 sec, (2) 100% EtOH for 30 sec, (3) Carnoy’s fluid, a 
mixture consisting of 60% EtOH, 30% chloroform (VWR Intern., Darmstadt) and 10% 
acetic acid (Merck) for 2min [133, 134], (4) 100% EtOH for 30 sec, (5) purified water 
(ddH2O) for 30 sec and (6) 100% EtOH for 30 sec. Lipid washing was followed by an 
overnight drying step in the desiccator at RT.  
 
For the measurement of FFPE tissue samples, a de-waxing protocol was carried out 
by Malgorzata Muhm. The protocol comprises the application of (1) two times n-hexane 
(VWR Intern.) for 5min, (2) 100% EtOH for 5min and (3) ddH2O for 1min.  
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4.2.4 Multimodality imaging 
 FTIR imaging 
FTIR experiments were performed using a Spotlight 400 FTIR Imaging System (Perkin 
Elmer Germany, Rodgau). Before each image acquisition, the device was precooled 
by liquid nitrogen and detector check and aperture correction were performed using 
the Spectrum IMAGE (Perkin Elmer Germany) software. After calibration, tissue-
samples on metal-coated slides were placed onto the slide holder. Images used for 
virtual dissection experiments and feature extraction were taken in the range of 4000-
650 cm-1 with a spectral resolution of 8 cm-1 and a 25x25 μm pixel size. Images 
recorded for FTIR-guided, exclusive MALDI-FTICR MSI acquisition were recorded in 
the range of 3200-750 cm-1 with a spectral resolution of 12 cm-1 and spatial resolution 
of 6.25 μm. For all measurements, the reflection mode acquisition was specified in the 
Spectrum IMAGE software. During image recording, mirror velocity was set to 2.2 cm/s 
in order to reduce acquisition time. Furthermore, it was selected that the stored mean 
spectrum per pixel would be calculated based on two scans. For each experiment, a 
tissue-free reference point on the metal-coated slide surface was measured at identical 
parameters prior to FTIR image acquisition in order to enable automated background 
subtraction performed in Spectrum IMAGE. 
 
 Matrix application for MSI 
MALDI matrix was deposited on all tissue slides mounted on gold- or ITO-coated slides 
using the SunCollect automatic sprayer (SunChrom, Friedrichsdorf). Air pressure was 
set to 2.5 bar with a distance of 25.3 mm between spray head and tissue surface. 
Matrix substance and application workflow were adjusted with respect to the molecular 
features of interest during subsequent MS acquisition:  
 
Slides designated for reflector positive MS measurement of lipids and small 
molecules were coated with five layers of 60 mg/ml 2,5-dihydroxybenzoic acid 
(DHB; Bruker Daltonics) in acetonitrile (ACN; VWR Intern.)/ ddH2O/ trifluoroacetic 
acid (TFA; Merck) solution (50/49.5/0.5, v/v/v). The initial layer was applied at 
10 μL/min, followed by a second layer at 15 μL/min and three layers at 20 μL/min. All 
layers were deposited using the SunChrom slow spraying option (400 mm/min).  
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Slides designated for reflector negative MS measurement of lipids and small 
molecules were coated with nine layers of 5 mg/ml phenyl-α-cyanocinnamic acid amide 
(PhCCAA; SiChem, Bremen) in 90% acetone (VWR intern.). The first three layers were 
applied at 10/15/20 μL/min, followed by six layers at 25 μL/min. Matrix coating was 
performed using the fast spraying option (800 mm/min). 
 
Slides designated for subsequent linear detector positive MS measurement of 
protein signals were sprayed with five layers of 60mg/ml sDHB MALDI matrix (Bruker 
Daltonics) in ACN/ ddH2O/ TFA solution (40/59.5/0.5, v/v/v). The initial two layers were 
applied using a flow-rate of 10 μL/min followed by three layers at 15 μL/min. A drying 
step of 3 min at 37°C was introduced between each spraying step. Layers were spotted 
using the slow spraying option.  
 
Prior to matrix application, 1 mL of the Bruker peptide calibration standard I was 
pipetted onto a free slide-spot to enable mass axis calibration during subsequent 
reflector MALDI-MS acquisition of lipids and smaller molecules. Similarly, 1 mL of the 
Bruker protein calibration standard II was applied prior to the subsequent analysis of 
linear detector MALDI-MS acquisition. 
 
 MALDI-TOF-MSI 
MALDI-MSI experiments were performed on an ultraflex MALDI-TOF/TOF mass 
spectrometer mass spectrometer (Bruker Daltonics). Data acquisition parameters, 
i.e. laser shots per pixel, pixel size and acquired mass range, were specified in the 
flexControl software (Bruker Daltonics) and varied between the experiments. For all 
experiments, an optical image of the tissue-bearing object carrier was recorded before 
placement into the mass spectrometer by using a CanoScan 9000F Mark II optical 
scanner (Canon Deutschland GmbH, Stuttgart). Reflector negative images of NPC1 
I1061T knock-in mice brain sections were measured in the range of 100-2000 m/z 
using 500 laser shots per pixel and a laser raster width of 50 μm. Single measurements 
on the previously applied Bruker peptide calibration standard I spot were used to 
enable mass axis calibration by auto-correlation to a pre-defined list of corresponding 
peaks. Thereby, the quadratic mass axis correction option was chosen in flexControl. 
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Single measurements were also used to manually define a suitable detector gain 
voltage and laser attenuation value. MS images of CD1 nu/nu mouse xenograft brain 
tissue sections were kindly measured on an Autoflex Speed MALDI-TOF/TOF mass 
spectrometer (Bruker Daltonics) by Dr. Sandra Schulz in reflector positive mode. The 
mass range of 4000-20000 m/z was recorded, using 500 laser shots per pixel and a 
laser raster width of 75 μm. After defining all necessary parameters in flexControl, the 
previously recorded optical image was used to define measurement areas in the 
acquisition software flexImaging 4.1 (Bruker Daltonics). Thereby, a point-based 
registration step, in which three image pixels and their corresponding MS motor axis 
positions are defined, is performed by the software to enable affine registration. Within 
the flexImaging software, measurement areas and/or ROI’s can then be manually 
defined.  
 
 MALDI-FTICR-MSI 
Ultrahigh-resolution MS images were acquired on a 7T SolariX XR MALDI-FTICR-MS 
(Bruker Daltonics) with the kind support of Dr. Bogdan Munteanu who defined all 
acquisition parameters needed in the ftmsControl software (Bruker Daltonics). The 
FTICR-MS device is equipped with an Apollo II dual MALDI/electrospray 
ionization (ESI) ion source and a 2 kHz Smartbeam II laser (Bruker Daltonics). 
Acquisition parameters were set in order to record in negative-ion mode within the m/z 
range 150-4000 using absorption mode and a 512 kB data point size. Data point lateral 
resolution was set to 20 μm and 40 laser shots were applied per measurement 
position. Single measurements on the previously applied Bruker peptide calibration 
standard I were used to perform mass axis correction and define a suitable laser 
attenuation value. Similarly to MALDI-TOF-MSI, measurement areas and ROIs were 
defined by using the flexImaging 4.1 software that performed three-point registration 
between manually selected motor axis positions and their corresponding pixels in an 
opical image of the object carrier.  
 
 H&E staining 
For the purpose of correlation between FTIR-segmentation, MS signal distribution and 
tissue morphology, cryosections were stained in a multi-step workflow with 
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hematoxylin and eosin (H&E), a standard histological procedure. The staining protocol 
included 5 major steps. First of all, potential matrix residues were removed by 
subsequently dipping the slide in (1) 50% methanol (MeOH) for 3 min, (2) 70% MeOH 
for 3 min, (3) 100% MeOH for 5 min and (4) 100% ACN for an additional 5 min. In a 
second step, the section got rehydrated by adding (5) tap water for 5 min, followed by 
(6) ddH2O for 5 min. After rehydration, cell nuclei were stained as follows: 
(7) hematoxylin for 2 min, (8) tap water for 3 min, (9) ddH2O for 10 sec, (10) 0.3% acid 
alcohol for 30 sec, (11) ddH2O for 10 sec, (12) blueing solution consisting of sodium 
hydrogen carbonate (Merck)/ magnesium sulfate (AppliChem)/ ddH2O 
(0.2/2/97.8, w/w/v) for 2 min. Eosinophilic compartments were stained with 
(13) 0.5% eosin Y for 2 min followed by (14) ddH2O for 1min. In the final step, the 
cryopreserved section got dehydrated by dipping the slide in (15) 80% EtOH for 2 min, 
(16) 96% EtOH for 2 min and finally (17) 100% EtOH for 2 min. H&E staining of GIST 
tissues was carried out by Maria Deligianni at the pathology institute of the University 
Medical Centre Mannheim . Optical images of H&E stained tissues were taken by using 
an Aperio CS2 slide scanner (Leica Biosystems).  
 
4.2.5 Image processing and multivariate statistical evaluation 
 FTIR image pre-processing 
In accordance with biomedical practice [39, 135], a script consisting of multiple steps 
was written in MATLAB (The Mathworks) for pre-processing. Initially, spectra were 
spatially smoothed by means of an edge-preserving denoising (EPD) function that was 
kindly provided by Dr. Markus Grasmaier [136, 137]. Spectra were then 
baseline-corrected using a self-written script that performs asymmetric least squares 
smoothing with a smoothing factor λ = 1000000 and a weighting factor p = 0.01, as 
suggested by Eilers and Boelens  [138, 139]. Corrected spectra were subjected to first 
derivative calculation using MATLAB’s diff function and a script that performs standard 
normal variate (SNV) normalization which consists of mean centering and division by 
the standard deviation over the spectral intensities, thus giving the resulting spectra a 
unit standard deviation of one [140]. Spectral windows within the ranges 3100-2900 
cm-1 and 1800-950 cm-1 were selected using MATLAB’s find function and the 
remaining wavenumbers that don’t comprise vibrations most relevant in biomolecules 
were discarded.  
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 MSI pre-processing 
Pre-processing of MS data was carried out in R programming language by utilizing a 
‘MALDIquant’ package-based workflow routine that was developed by Denis 
Abu-Sammour (unpublished) [141]. Spectra were corrected using total ion current 
(TIC) normalization, which divides the intensity of a spectrum by its TIC (sum of all ion 
intensities) and then multiplies by the median TIC of all spectra. Normalized spectra 
were subsequently subjected to Top Hat baseline correction [142], a morphological 
filter that combines a moving minimum (erosion filter) followed by a moving maximum 
(dilation filter). To further minimize dimensionality, peak picking using the Friedman’s 
Supersmoother was applied with a signal-to-noise (S/N) threshold of S/N > 3 [143]. In 
order to make the data accessible to MATLAB, the raw and preprocessed spectral 
information was converted to text file format (csv). 
 
 Dimensionality reduction and evaluation of FTIR and MS data 
Principal component analysis with the purpose of dimensionality reduction of FTIR and 
MS imaging data was carried out in MATLAB by utilizing the pca function. Thereby, 
default parameters were used with the exception of NumComponents, which was set 
to three in order to enable 3D-visualization of the transformed spectra.  
 
In a similar fashion, t-distributed stochastic neighbor embedding was performed by 
utilizing MATLAB’s tsne function. The function’s Distance parameter which defines the 
underlying metric was set to cityblock and the NumDimensions parameter was set to 3 
in order to enable 3D-visualization.  
 
Feature selection and MS peak selection using local maxima identification was 
achieved by using the findpeaks function in MATLAB with default parameters.  
 
The dispersion of transformed data points in tSNE or PCA space was evaluated by 
calculating the MAD. This was achieved in MATLAB by using the mad function and 
default parameters.  
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 Image segmentation and cluster evaluation 
FTIR images were segmented in MATLAB using the kmeans function with cityblock 
distance metric and 3 Replicates using new initial cluster centroid positions [121]. The 
needed value k that denotes the cluster’s number of allocation groups was pre-defined 
based on the examined tissue specimen. Evaluation of FTIR segmentation results for 
different k-values was done by using MATLAB’s evalclusters function with criterion 
being set to CalinskiHarabasz. Thereby, the respective kmeans algorithm was 
specified with a function handle. The highest computed criterion was then assumed to 
correspond to the optimal cluster number.  
 
Similar to FTIR segmentation, MS images for comparative analyses were dissected in 
R programming language by Denis Abu-Sammour. In this context, the ‘MALDIquant’ 
package was utilized to enable k-means++ segmentation as well as state-of-the-art 
spatially-aware clustering that enables a more stable segmentation of large and 
highly-dimensional data sets [144]. MSI-based segmentation results were converted 
to text file format (csv) in order to make the data accessible to MATLAB.  
 
 Registration of binary images and efficacy estimation 
Binary information depicting the presence and absence of tissue was extracted from 
images obtained with different sensors for registration purposes. This was achieved by 
means of k-means++ cluster analysis using the kmeans function in MATLAB and the 
cityblock distance metric. Segmentation of spectra obtained on tissue and plain surface 
by the use of (k = 2)-clustering was considered to separate between background and 
on-tissue signals, as they differentiate the most. Therefore, a binary image was created 
by setting all pixels belonging to the allocation group with less mean absorption to zero 
and the remaining pixels with higher mean absorption to one. Subsequently, the 
geometric transformation matrix needed for registration between the binary images 
was calculated in MATLAB by utilizing the imregtform function with transformType 
being set to affine. The function’s optimizer and metric parameter were given by the 
imregconfig function with modality being set to monomodal. The derived geometric 
transformation matrix could then be used to register the moving binary image’s original 
sources. This was done by using the imwarp function in MATLAB. In order to assess 
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registration efficacy, a self-written script that calculates the DSC between moving and 
fixed binary image was utilized.  
 
 Extraction of discriminatory features 
MS and FTIR features that are rich in discriminatory power with respect to tissue 
classification were extracted by using the rankfeatures function in MATLAB. The 
utilized Criterion was set to roc in order to enable ROC-based feature extraction. For 
the remaining parameters of rankfeatures, default values were used.  
 
 Evaluation of spectral similarity 
The degree of linear correlation between spectra was assessed by calculating the 
sample Pearson correlation coefficient. Thereby, the corrcoef function in MATLAB was 
utilized with default parameters.  
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5 RESULTS 
The results of this thesis will be subdivided into four major parts which revolve around 
its major objectives: 
 
1) The first part presents single modality capabilities of FTIR and MALDI-MS 
imaging with respect to segmentation and classification. In this context, the 
influence of different slide-coating materials and fixation is investigated.  
 
2) In the second part, the technical and computational development of a sensitive, 
robust and reproducible multimodality imaging workflow that utilizes the concept 
of guidance in order to combine FTIR micro-spectroscopy and MALDI-MSI is 
presented.  
 
3) The third and major part focusses on evaluation of the developed workflow for 
discriminatory purposes in animal and human tissue samples. The capability of 
identifying divergent cell populations (i.e. tumors) as well as extracting 
morphology-dependent marker signatures, is examined.  
 
4) Lastly, the computational and practical challenges related to high 
mass-resolution MSI are addressed by presenting a more integrated 
multimodality imaging workflow that enables unbiased targeting of tissue 
morphologies prior to MSI acquisition.  
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5.1 Exploration of single modality capabilities 
Single modality experiments were carried out in order to evaluate the multimodality 
capabilities of FTIR micro-spectroscopy and MALDI-MSI. The main focus was to 
demonstrate modality-dependent advantages of FTIR imaging that would provide the 
basis for its beneficial integration into a multimodality imaging workflow. In this context, 
the impact of technical parameters like slide-coating composition, fixation and storage 
was examined with respect to tissue segmentation and characterization.  
 
5.1.1 The influence of object slide coating on FTIR spectroscopy 
The substrate composition on which FTIR measurements are performed has a critical 
effect on image quality [145] and potentially influences tissue segmentation. In general, 
metal substrates like gold, aluminum or MirrIR, a reflective silver and tin 
oxide (Ag/SNO2) multilayer coating, are used for reflection measurements. In order to 
determine the optimal optical substrate for FTIR tissue imaging, these three different 
substrate composition slides were evaluated. Porcine 8 μm liver tissue sections were 
chosen due to their high cellular homogeneity and mounted on ITO-, MirrIR- and gold-
coated slides. Indium tin oxide slides were examined as they represent the standard 
material for MALDI-TOF MS [146, 147] that permits visible light transmission and good 
conductive properties [148]. For each slide’s substrate composition, the mean 
mid-infrared background absorption of 60 scans was recorded (Fig. 8A) prior to 
triplicate measurements (Fig. 8B) of rectangular on-tissue areas that consisted of 
1600 spectra each. All recorded spectra were computed in PCA space (Fig. 8C) in 
order to visualize each image’s dispersion. Thereby, 88.67% of the original data’s 
variance was preserved within the first three PCAs. 
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Figure 8 FTIR reflection measurements on different substrate composition slides (A) FTIR background 
absorption was acquired on gold-, ITO- and MirrIR-coated microscopy slides prior to subsequent 
measurement of 8 μm porcine liver tissue cryosections. For each liver section, three rectangular measurement 
areas consisting of 1600 positions with a pixel size of 25x25 μm were defined using the Spectrum IMAGE 
software. (B) Comparison of each acquisition area’s mean spectrum reveals a higher overall absorption (lower 
S/N) when using ITO-coated slides. The spectra acquired on gold- and MirrIR-coated object carriers appear 
comparable with a slightly higher mean absorption on gold. (C) By transforming all 14400 spectra into PCA 
space, the dispersion created by each carrier’s coating was visualized. It becomes apparent that FTIR spectra 
acquired on ITO are less stable when compared to gold or MirrIR.  
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The monitored background absorption on each coating material appeared comparable, 
though an increased absorption in the range of 1200-800 cm-1 was observed with 
ITO (Fig. 8A). Moreover, an increased mean absorption (65.99%) was observed for 
tissue spectra acquired on ITO when compared to on-tissue measurements using 
gold- (41.04%) or MirrIR-coated object slides (27.12%). This difference was found to 
be mainly caused by a comparatively increased base-intensity. As more than 40% of 
the incident light was absorbed in the range of 2550-1700 cm-1 that is considered 
devoid of biomolecular vibration signals (Fig. 8B), it can be assumed that the coating-
material itself absorbs mid-infrared radiation and therefore dilutes spectral information 
content. The negative influence of ITO coating can further be emphasized by 
transforming all recorded spectra into three-dimensional PCA space (Fig. 8C). 
Assuming that liver tissue is homogeneous, all recorded spectra should fall together 
after transformation. However, a considerably increased data spread could be 
observed for ITO-derived spectra. As a quantitative measure of spectral dispersion, 
the MAD-value was calculated for each sample set, confirming a higher stability for on-
MirrIR infrared acquisition (MAD = 3.51) when compared to ITO (MAD = 7.21) or 
gold (MAD = 4.32).  
 
However, spectral quality does not necessarily denote segmentation efficiency. In 
order to investigate the influence of different coating-composition materials on 
segmentation, subsequent murine C57BL/6 brain tissue cryosections of 8 μm 
thickness were mounted on gold-, ITO- and MirrIR-coated object slides. The brain was 
chosen as a suitable test model due to its heterogeneous morphological composition. 
In order to elucidate the accuracy of image dissection, the Allen Brain Reference 
Atlas [149], which summarizes publicly available data about the brain’s structural 
composition (Fig. 9A) was used as a reference. The derived contours obtained from 
dissecting each FTIR image into seven segments by means of (k = 7) k-means++ 
cluster analysis were color-coded by assigning a unique color to each pixel of a given 
index (Fig. 9B). Image dissection into seven segments was chosen based on the 
calculated Calinski-Harabasz criterion CHc for all k-values in the range of 5-10. The 
retrieved CHc suggested an optimal number of seven clusters for the acquired on-gold 
image as well as the acquired on-MirrIR image and five clusters for the acquired 
on-ITO image. In order to compare between segmentation results, all images were 
partitioned based on the highest retrieved cluster optimum and optically compared to 
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structural brain atlas regions (Fig. 9A). Thereby, matching colors were assigned to the 
pixels of each allocation group. As indices are randomly assigned during cluster 
analyses, comparable images were manually selected out of all 5040 possible 
color-coded maps (Fig. 9B). All retrieved segmentation images showed a rough 
division into morphological brain tissue regions, namely hippocampal region, fiber 
tracts, thalamus, hypothalamus and isocortex. In comparison, dissection of FTIR 
images recorded on ITO appeared noisy with less defined contours and poor rendering 
of the thalamus region (Fig. 9C). Interestingly, spectral dissection on gold-coated 
object slides additionally uncovered the granule cell layer of the dentate gyrus and 
cornu ammonis brain region (Fig. 9D). This granule cell layer is subject to multiple 
neurological disease studies i.e. on Alzheimer [150], epilepsy [151] and 
electroconvulsive therapy [152].  
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Figure 9 FTIR reflection based brain tissue segmentation on different substrate composition slides 
(A) The Allen Brain Reference Atlas (Image credit: Allen Institute Mouse Brain Atlas [149], P56, Coronal, 
Image 76 of 132) illustrates a mouse brain’s structural makeup that enables comparison to (B) the spatial 
contours derived by (k = 7) k-means++ clustering of FTIR images recorded on slides coated with different 
substrate materials (ITO, MirrIR, gold). Images were recorded on subsequent cryosections of the same 
C57BL/6 mouse brain sample. The obtained cluster results were used to express spectral grouping in a color-
coded image, revealing spectral differences linked to morphological regions, namely fiber tracts, thalamus, 
hypothalamus, isocortex and hippocampal region. (C) Exemplified comparison of the thalamus-section’s 
contours reveals poor rendering of the ITO-retrieved segmentation image. (D) Magnification of the 
hippocampal region and the yellow cluster of the on-gold acquired FTIR image demonstrates the identification 
of an additional region of interest, namely the granule cell layer of the dentate gyrus and cornu ammonis 
brain region  
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In summary, FTIR imaging on ITO-coated slides led to poorer spectral quality and less 
stability. Spatial contours after segmentation were blurry and revealed less 
morphological structures. The use of MirrIR-coated slides resulted in images of 
improved spectral quality with less dispersion and a good resolution of the amide I&II 
region (1500-1700 cm-1) and the fingerprint region (600-1450 cm-1). Spectral 
measurements on gold appeared slightly worse. However, segmentation results were 
of comparable quality and revealed additional morphological structures. 
 
5.1.2 The influence of object slide coating on MS quality  
The conductive properties of different substrate coatings and their interaction with the 
electronic states of matrix molecules have been proven to influence the ionization 
process of MALDI- [153], DESI- [154] and other MSI techniques [155]. In order to 
elucidate the influence of different substrate composition materials on spectral 
MALDI-MSI quality, subsequent porcine liver sections of 8 μm thickness were placed 
on ITO- and gold-coated slides. MirrIR-coated slides were not used as they didn’t fit 
into the Bruker target plate holder. Tissues were sprayed with DHB in 
ACN/ ddH2O/ TFA (50/49.5/0.5, v/v/v) using the SunChrome spraying system. To 
ensure comparability, both object slides were jointly put in the same plate holder, and 
reflector positive MS images were subsequently acquired with identical parameters. 
For each liver section, three rectangular regions consisting of roughly 50 acquisition 
spots were defined in flexImaging. The mean spectra of 177 mass spectra acquired on 
ITO and 169 mass spectra acquired on gold were compared (Fig. 10).  
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The resulting tissue pattern was comparable between spectra acquired on gold and 
ITO. In general, peak intensities on gold were higher and no negative influence of 
on-gold MALDI-MSI was observed with respect to m/z-signals. On the contrary, peak 
selection using local maxima identification in MATLAB identified a higher number of 
peaks (992) within mass spectrometry data recorded on gold when compared to MS 
data recorded on ITO (740). However as this experiment was only carried out once, it 
is difficult to assume better spectral quality for on-gold measurements. In order to 
compare each data set’s dispersion, all recorded mass spectra were transformed by 
means of PCA and each spectrum’s position within the first 3 PC space was 
visualized (Fig. 11). Thereby, 89.86% of the original data’s variance was preserved. 
 
 
Figure 11 PCA transformation of MS data acquired on gold- and ITO-coated slides. 
Porcine liver tissue sections were mounted on different metal-coated object carrier and 
subsequently used for reflector positive MS measurements. Visualization of all 177 spectra 
acquired on ITO and 169 spectra acquired on gold within the first three PCs demonstrate 
distinct clustering based on the used coating material.  
 
The transformed mass spectra acquired on gold and ITO formed two distinct clusters 
which emphasizes the influence of substrate composition on MALDI-MSI. After 
normalization, the calculated MAD revealed an increased scattering of 6.1% for 
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on-gold MSI (MAD = 6.05*10-4) when compared to on-ITO measurements 
(MAD = 5.7*10-4). In comparison to FTIR imaging results (chapter 5.1.1) for which the 
dispersion on ITO was increased by 66.9% when compared to gold, this difference in 
dispersion appears less significant. In summary, the use of gold-coated object slides 
led to no observable major negative effects, although the obtained spectra were easily 
distinguishable in PCA space. As this experiment was carried out only once, it remains 
uncertain whether the distinct clusters indicate improved or worsened spectral quality 
when measuring on gold-coated object slides. Based on these observations and taking 
into account the results obtained in chapter 4.1.1, gold was chosen as the material of 
choice for multimodal acquisition in both systems.  
 
5.1.3 Tissue segmentation by FTIR and MS imaging 
The differences between FTIR segmentation for later MSI guidance and direct MS 
image segmentation were compared. Brain tissue sections of CD1 nu/nu mice 
inoculated with orthotopic U87-MG glioblastoma xenografts were chosen as a suitable 
test case with rather homogenous lesions. Subsequent sections of 8 μm thickness 
were mounted on gold- and ITO-coated slides for FTIR spectromicroscopy and MS 
imaging respectively. H&E stains of on-gold tissues (Fig. 12A) were prepared after 
FTIR image acquisition to serve as a reference for the evaluation of FTIR- and MS 
image segmentation results. FTIR- images were partitioned by means of k-means++ 
cluster analysis with an increasing number of centroids (k = 3, k = 4, k = 5). Thereby, 
the spatial coordinates of all spectra were color-coded based on their allocation to a 
given centroid. As indices were randomly assigned during each cluster analysis, each 
segmentation image received an independent color-code. The obtained segmentation 
images were compared to MSI–based segmentation results using k-means++ 
clustering as well as state-of-the-art spatially-aware clustering that were provided by 
Denis Abu-Sammour. In this context (Fig. 12B), dissection of MS images using 
spatially-aware clustering methods (MSspk) was found to be less noisy and featured 
sharper segment-contours when compared to k-means++ based MS segmentation 
(MSk++). Despite the lack of histopathological annotation which impedes quantification 
assessment of segmentation accuracy, the fit between tumor boundaries visible in 
H&E stains and the FTIR-based k-means++ segmentation image (IRk++) appeared to 
be significantly better when compared to MS-based segmentation results. Dissection 
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using five centroids (k = 5) added additional morphological information to FTIR 
segmentation images and revealed to some extend tumor boundaries in MSk++ which 
were not observable for lower k-values. In MSspk images, increasing k added no 
additional morphological information.  
 
 
Figure 12 FTIR- and MS-based segmentation of engrafted mouse brain sections.  Brain cryosections of 
CD1 nu/nu mice inoculated with human U87-MG glioblastoma cells were mounted on gold-coated slides. 
(A) After FTIR and MALDI MS image acquisition, H&E stains of the measured sections were prepared to 
visualize the spatial distribution of tumor cells. Based on this reference, (B) segmentation results based on 
the previously obtained FTIR- and MS images were evaluated. The recorded images were in-silico dissected 
into multiple areas (k = 3, k = 4, k = 5) of greatest possible data homogeneity. Each spectrums allocation was 
used to create a color-coded image in which identical colors represent spectral similarity. The resulting 
segmentation images derived from k-means++ clustering of FTIR- (IRk++) and MS images (MSk++) as well as 
spatially-aware clustering of MS images (MSspk) are compared.  
 
For the purpose of quantifying each modality’s potential to monitor tumors in tissues 
by means of segmentation analyses, images of resected human tissue samples 
containing GIST were recorded. For reference purposes, adjacent sections were 
prepared on Starfrost adhesive slides and subsequently H&E-stained (Fig. 13A). 
Histopathological annotation was provided by the Pathological Institute at the 
University Medical Center Mannheim (red marks). FTIR-images were dissected into 
three areas of greatest homogeneity using (k = 3) k-means++ cluster analysis and 
compared to MSI–based kmeans++ and spatially-aware image segmentation results 
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provided by Denis Abu-Sammour. The k-value needed for image partitioning was set 
to three based on the preceding U87-MG glioblastoma xenograft segmentation results 
for which k = 3 sufficed to visualize tumor contours. The obtained spectral allocation 
results were then used to form a color-coded segmentation image (Fig. 13B). Both the 
annotated tumor contours as well as the matching colored segments were converted 
to binary in order to quantify similarities. The segment-retrieved moving 
black-and-white images were registered to the fixed tumor annotation image by using 
automated intensity-based image registration tools in MATLAB (Fig. 13C). As a 
measure of precision, the DSC which quantifies the overlap between tumor contours 
and each modality’s segment binary was calculated. Disaggregation based on FTIR 
data (DSC = 0.881) was proven to better represent tumor contours when compared to 
MS-based segmentation using spatially-aware clustering (DSC = 0.505) or k-means++ 
cluster analysis (DSC = 0.383).  
 
 
Figure 13 FTIR and MS based segmentation for tumor recognition in human GIST tissue samples. (A) H&E 
stains of human patient-derived GIST tissues were pathologically annotated to localize tumor areas. (B) IR and 
MS images recorded on subsequent cryosections were in-silico dissected into three areas (k = 3) by performing 
k-means++ clustering of IR (IRk++) and MS data (MSk++). Additionally, MS images were dissected using 
spatially-aware clustering (MSspk). For visualization, the retrieved segments were color-coded (red, green, blue). 
(C) Evaluation of each segmentation’s efficacy was achieved by converting the pathologically annotated tissue 
area as well as the matching segment to binary. The retrieved images were overlaid by means of intensity-based 
registration, showing matching pixels (white) as well as areas unique to the pathological annotation (green) or 
segment (magenta). Calculation of the DSC demonstrates a more precise tumor identification (DSC = 0.881) for 
FTIR-based tissue disaggregation when compared to MS-based segmentation. Tissue dissection of MS data by 
means of spatially-aware clustering proved superior (DSC = 0.505) when compared to MSk++ (DSC = 0.383).  
 
In conclusion, segmentation of FTIR images proved to add critical information about a 
tissue’s morphological makeup when compared to MS image clustering. In addition, 
the technique operates comparatively fast and is less computationally expensive. FTIR 
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images of 25 μm spatial resolution were recorded in 65 min for both glioblastoma 
mouse brain sections and 8 min for the presented GIST section. In contrast, MS 
images of both glioblastoma brain sections featured a lower spatial resolution of 75 μm 
and recording took 6.1 h on the ultrafleXtreme MS instrument. The presented GIST 
MS image was recorded in 54 min at 50 μm resolution.  
 
5.1.4 Feasibility of FTIR imaging on FFPE tissues  
Tissue embedding is known to have a critical influence on spectral quality in both MS 
and FTIR imaging. It is therefore a major obstacle, as histopathological examination 
and storage is typically done using FFPE tissues. Although de-waxing protocols have 
been proposed for FTIR imaging, little is known about the effect of FFPE residues and 
de-waxing on spectral quality and segmentation. In order to evaluate FTIR’s capability 
to record and dissect FFPE tissues, embedded, de-waxed and cryopreserved porcine 
kidney samples were mounted on MirrIR-slides. The derived MIR-spectra recorded on 
two embedded, two de-waxed and two cryopreserved liver sections were 
compared (Fig. 14). Thereby, calculation of the sample Pearson correlation coefficient 
as a quantitative measure of spectral similarity revealed that de-waxing led to an 
increased linear correlation between MIR-spectra acquired on FFPE and 
cryopreserved tissues (R = 0.95) when compared to untreated FFPE 
tissues (R = 0.89). However, an increased mean absorption was observed for 
MIR-spectra acquired on FFPE (56.2%) and de-waxed (60.8%) tissues in comparison 
to measurements on cryopreserved material (25.9%).  
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Figure 14FTIR measurements on formalin-fixed paraffin-embedded tissues.  Comparison of MIR-
spectra acquired on FFPE and de-waxed tissues reveals a higher overall absorption when compared to 
cryopreserved materials. Spectral differences are mainly observed in the ranges of 3010-2850 cm-1 and 1460-
1470 cm-1 in which CH2-associated symmetrical (νs) and antisymmetrical stretch (νas) as well as symmetrical 
bending vibrations (δs) occur. Spectral correlation was quantified by calculating the smaple Pearson 
correlation coefficient which confirms a higher correlation of cryopreserved material to de-waxed 
tissues (R = 0.95) than to FFPE tissues (R = 0.89).  
 
The calculated differences were found to be caused by a comparatively increased 
base-intensity (2550-1700 cm-1) and an increase in the wavenumber-ranges 
3010-2850 cm-1 and 1460-1470 cm-1 that are associated to CH2-vibrations. For this, it 
can be concluded that the typically lipid-associated CH2-signals are overlaid by the 
CH2-bonds of paraffin (C20H42) which impairs spectral quality. Although de-waxed 
tissue samples also featured an increased base-intensity, no relative increase in the 
ranges 3010-2850 cm-1 and 1460-1470 cm-1 could be observed. In order to evaluate 
the segmentation of de-waxed tissue samples, a human derived prostate cancer 
FFPE-section was mounted on a MirrIR-coated tissue slide and de-waxed prior to FTIR 
image acquisition. The FTIR image was partitioned into five clusters by means of 
(k = 5) k-means++ segmentation in accordance to the optimal cluster number denoted 
by the Calinski-Harabsz criterion (Fig. 15). For comparison, histopathological 
annotation of a subsequent section was provided by the Pathological Institute at the 
University Medical Center Mannheim (black mark). In the derived segmentation image, 
no tumor-describing segment could be observed. Instead disperse clusters were 
obtained that might refer to other tissue morphologies, namely smooth muscles (blue), 
gland cells (green) collage-rich capsule (orange).  
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Figure 15 Comparison between H&E-stained human prostate cancer tissue and subsequent FTIR 
image segmentation. Two adjacent FFPE tissues of a prostate cancer quick section were designated 
to H&E staining and FTIR image acquisition after de-waxing. The tumor area was highlighted (black 
mark) after pathological examination at the University Medical Center Mannheim. In comparison to the 
color-coded image provided by (k = 5) k-means++ segmentation of the FTIR image, no segment could 
be linked to the occurrence of tumor. Instead, disperse segments that might refer to other tissue 
morphologies were observable.  
 
In summary, no correlation between the occurrence of prostate cancer and IR 
segmentation was observable. More comprehensive studies of different tissue types 
would be needed to evaluate the feasibility of on-FFPE measurements for tissue 
segmentation.  
 
5.1.5 Reproducibility of FTIR image segmentation  
Storage conditions could have a striking influence on the obtained infrared signals of 
tissue materials. To further elucidate the long-term effects of storage, subsequent 
sections of the murine brain samples with human U87-MG glioblastoma xenografts 
(presented in chapter 5.1.4) were mounted on gold-coated slides and kept in a 
desiccator at room temperature for three years. FTIR images were recorded and 
segmentation results of both the stored  image and the image that was recorded three 
years earlier were compared. Thereby, images were partitioned into seven segments 
by means of (k = 7) k-means++ cluster analysis, as denoted by the CHc of previous 
brain tissue experiments (presented in chapter 5.1.1).. Allocation-based color-coding 
of pixels revealed comparable morphological brain structures as well as the area of 
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infiltrating glioblastoma cells in both segmentation images (Fig. 16A).In order to 
quantify the structural similarities, both images were registered into a common 
coordinate system and the DSC was calculated for each corresponding segment-pair, 
revealing a mean overlap of 58.9% (DSC = 0.589 ± 0.211) between the identified 
structures. In this context, the individual DSC-values per segment-pair varied greatly, 
with the isocortex contours detected after three years being the least similar (DSC = 
0.134) to the original image’s contours and the infiltrating tumor zone (DSC = 0.908) 
and fiber tract contours (DSC = 0.746) being the most similar. In addition to structural 
similarities, the respective mean infrared spectra acquired for cerebellar fiber tracts 
and tumor cells were comparable in both images (Fig. 16B). This observation was 
quantified by calculating the Pearson correlation coefficient [127], as a measure of 
spectral similarity. Thereby, a high mean spectral correlation (R = 0.972 ± 0.004) 
between all identified segment-pairs was confirmed.  
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Figure 16 Long term reproducibility of FTIR image segmentation.  Brain tissue sections derived 
from CD1 nu/nu mice inoculated with U87-MG glioblastoma cells were stored in a desiccator at room 
temperature. FTIR images were recorded prior to storage and after three years for comparative cluster 
analysis. (A) Image dissection by means of (k = 7) k-means++ analysis leads to comparable color-
coded segmentation and reveals the spatial contours. Calculation of the Dice similarity coefficient 
between matching segments reveals structural similarity of fiber tracts (DSC = 0.746) and infiltrating 
glioblastoma cells (DSC = 0.908). (B) Comparison of the respective mean spectra for both spatial 
features also demonstrates spectral comparability. This was quantified by calculating the Pearson 
correlation coefficient which confirmes high similarity (R = 0.972 ± 0.004). 
 
In summary, the long-term stability of FTIR image structures appears to vary for 
different cell populations. Whereas the contours of infiltrating tumor cells and white 
matter were still observable after three years, grey matter structures, i.e. isocortex, 
were found to cluster differently. Despite these structural differences, mid-infrared 
spectra appeared long-term stable as the spectra recorded in 2014 and 2017 showed 
high linear correlation. More comprehensive studies of different tissue types would be 
needed to evaluate the influence of storage conditions on segmentation results.  
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5.2 Development of an automated multimodal imaging workflow 
An established routine in clinical MALDI-MSI is the analysis of serial whole-tissue 
samples. In order to extract valuable analytical information out of the resulting large 
data volumes, subsequent histological stains of the analyzed specimen are typically 
co-registered and used to manually define striking morphological regions. The 
respective mass information is then used to assess additional in-depth molecular 
characteristics, i.e. tumor-associated mass features. However, as shown in recent 
publications [21], only a small fraction of the recorded MSI data is used for later 
analyses. Moreover, the manual definition of striking areas constitutes an increased 
potential for errors.  
 
FTIR image segmentation can identify tissue substructures of morphological similarity 
in a more sensitive and robust manner when compared to direct MS clustering. 
Moreover, the acquisition of FTIR images is comparatively fast, which potentially 
facilitates their applicability within a clinical setting. Despite these advantages, the 
obtained MIR-information is insufficient to uncover the molecular coherences involved 
in disease formation. In order to combine the respective potentials of vibrational 
spectroscopy and mass spectrometry, a multimodal imaging workflow was developed 
that utilizes the FTIR-derived structural information in order to guide subsequent 
MALDI-MSI experiments. In this context, technical and computational developments 
were made with respect to registration in order to generate templates for MS guidance 
out of FTIR spectra. 
 
5.2.1 Image registration to enable FTIR-MS workflow development 
In order to jointly utilize the spatial information obtained from infrared-based 
segmentation as well as the molecular information provided by MALDI-MS, a two-step  
concept was developed (Fig. 17), in which FTIR images of tissue cryosections are 
acquired prior to MSI-data acquisition. The derived FTIR-based segments after image 
pre-processing and virtual micro-dissection are then used as a template to define 
distinct, divergent cell populations (i.e. tumors or functionally important tissue 
morphologies) for MALDI-MSI. 
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Figure 17 Multimodal FTIR-guided MALDI mass spectrometry imaging. FTIR imaging is utilized in order to 
record a variable (Var) set consisting of p vibrational bands that represent biomolecular features. By applying 
segmentation, the spectra at any given pixel are assigned to a defined number of subgroups based on similarity. 
The membership of each pixel is expressed by assigning an exclusive index-value (IDX). The spatial properties 
of a segment that consists of all pixels belonging to a given IDX (SIDX) are registered to the follow-up modality, 
MALDI-MSI, thus allowing to target the q-dimensional mass variables for predefined pixels. FTIR and MS 
imaging measure orthogonal properties, consequently complementing contours of spatial accuracy that exceed 
MALDI-MSI capabilities with chemically specific mass information.  
 
In order to convert the FTIR image into the same coordinate system as the MALDI-MSI, 
a routine for automated registration was developed in MATLAB. A multi-step script 
aligns the recorded moving FTIR images to their corresponding tissue objects within 
the optical reference image which is used for MSI acquisition (Fig. 18). This enables 
FTIR-based guidance and interpretation of MS images, as the flexImaging software 
automatically links the position of each mass spectrum to its corresponding optical 
image pixel by means of affine point set registration. In an initial step, the MATLAB 
script converts both the FTIR and optical image into binary files by applying (k = 2) k-
means++ cluster analysis. Thereby, the segment with lower mean intensity is set to 
zero, as it is considered to resemble background and the remaining tissue-pixel are 
set to one. The generated binary files are then forwarded to intensity-based automatic 
image registration which, in an iterative process, estimates the geometric 
transformation matrix that aligns both images (Fig. 18). The process applies affine 
registration of an internally determined transformation matrix to the moving 
FTIR-derived binary image with bilinear interpolation. Then, the mean squares image 
similarity metric is computed between the transformed moving image and the fixed 
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binary of the optical image. The metric assumes similar image intensities and is 
generally only suitable for mono-modal registration [156]. However, the previous 
conversion of both images to binary, bypasses this limitation. Finally, a regular step 
gradient optimizer [157] adjusts the transformation parameters so that the optimization 
follows the gradient of the image similarity metric in the direction of the extrema at a 
constant step length. However, when the gradient changes direction, the step length 
is halved until either 100 iterations were performed or the step length falls below 10-5.  
 
 
Figure 18: Affine intensity-based automatic registration of FTIR and optical image.  The moving binary 
image originating from a recorded FTIR image is initially transformed with bilinear interpolation. Subsequently, 
the similarity between the transformed image and a fixed binary image originating from an optical image of the 
same specimen is calculated by means of mean squares image similarity. If the computed metric doesn’t fulfill 
the condition specified by the regular step gradient descent optimizer, the transformation matrix is adjusted and 
reapplied to the moving image. If the condition is matched or if a certain count of iterations is reached, the 
resulting optimized transformation matrix can align the starting FTIR image and optical image.  
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5.2.2 Evaluation of FTIR-to-MSI registration 
For the evaluation of registration efficacy, a murine brain section was prepared on gold 
and designated to FTIR acquisition (Fig. 19A). Four additional sections were mounted 
on a subsequent object carrier and an optical image was recorded (Fig. 19B). 
Registration was carried out in two subsequent steps. At first, both the FTIR and optical 
image were converted into binary images (background = 0, on-tissue signal = 1). 
Secondly, the geometric transformation matrix between the moving FTIR and the fixed 
optical binary image was calculated by means of intensity-based affine registration. 
Based on the retrieved geometric transformation matrix, the color-coded FTIR-based 
segmentation image (Fig. 19C) was aligned to match the contours of its subsequent 
section in the optical image (Fig. 19D).  
 
 
Figure 19 Registration of FTIR-derived segments to multiple subsequent sections used 
for MALDI-MSI. (A) A brain tissue section designated to FTIR image acquisition will be utilized 
to denote spatial properties in (B) subsequent sections designated to MALDI-MSI. (C) 
Morphological information is obtained by k-means++ (k = 3) segmentation of the acquired FTIR 
image. As a result, the image is getting partitioned into multiple color-coded areas of greatest 
spectral similarity. (D) After registration between the obtained moving FTIR and fixed optical 
MS image, the derived transformation matrix is used to adjust the segments spatial properties.  
 
For evaluation purposes, the transformation matrix was recalculated for each 
FTIR-to-subsequent brain tissue section pair, thus allowing the identical FTIR cluster 
image to be reoriented and rescaled to match all subsequent sections (Fig. 20A). The 
effectiveness of registration was quantified by calculating the DSC, which denotes the 
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percentage of overlap between the transformed moving FTIR and the fixed optical 
image (Fig. 20B). For this exemplary tissue series, a mean DSC of 0.975 ± 0.006 was 
calculated, which confirms the precise conversion of FTIR-derived segments.  
 
 
Figure 20 Evaluation of the automatic registration used for FTIR-guided MSI  (A) A single 
segmentation image (red-green) obtained from FTIR mouse brain image dissection by means of (k = 2) k-
means++ cluster analysis was registered to the optical image of four subsequent tissue sections. (B) 
Fusion of the binary masks that represent tissue contours in the FTIR- and optical image makes it possible 
to quantify registration efficiency. Calculation of the Dice similarity coefficient (DSC) is used as a measure 
of overlap (white) in relation to pixels that are only visible in the optical image binary (green) or FTIR 
derived binary (green).  
 
The established registration routine was incorporated into a multimodal workflow that 
makes use of the image acquisition file utilized to denote MALDI-MSI 
parameters (Fig. 21). Within the acquisition file, it becomes possible to define optical 
image pixel coordinates that frame the desired region of interest (ROI). In order to 
retrieve the optical pixels that resemble the spatial FTIR-based segmentation contours, 
the border pixels of each segment were automatically transformed according to the 
obtained geometrical transformation matrix. In this manner, the FTIR-derived spatial 
allocations are mapped onto the optical image used to define ROI’s that can be used 
to extract spatially defined mass spectra out of large and complex data volumes after 
whole-tissue measurements. 
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Figure 21 Schematic workflow diagram for FTIR-guided extraction of MSI data.  FTIR image acquisition of 
subsequent tissue sections on gold can be utilized to denote measurement regions and/or ROIs. The spatial 
contours are defined by segmentation of the FTIR image and subsequent registration to the optical image used 
for later MSI measurement. Modification of the MSI acquisition file enables targeted mass feature extraction and 
unbiased annotation. 
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5.3 Analytic applications of multimodality FTIR-MS imaging 
After developing a stable and versatile workflow for FTIR-MSI imaging, different case 
studies that exemplify the added benefit of the technique will be presented. In the 
following chapters, the workflow’s potency to target cell populations of high vibrational 
homogeneity for improved mass feature retrieval will be presented. Moreover, an 
untargeted approach that enables automated, morphology-dependent biomarker 
identification was examined. The proposed workflow was also utilized to assess tumor 
heterogeneity in human-derived cancer tissues. Lastly, slight adjustments to enable 
same-slice multimodality imaging were made, thus enabling targeted MALDI-MSI 
acquisition of pre-defined tissue regions.  
 
5.3.1 Automated FTIR-guided tumor-targeting and mass feature extraction 
The strength of FTIR image segmentation lies in its ability to partition the examined 
tissue into regions of the same or a similar profile. It can assess the divergent 
biomolecular composition between distinct tissue regions with more detail than 
established histochemical methods. Moreover, it can generate images of superior 
spatial resolution at a faster rate than MALDI-MSI.  
 
In that regard, the precise localization of tumor margins is a critical task in 
histopathology and, hence, serves as a relevant test case for the established 
multimodal workflow. As a suitable model, four female 6-12 weeks old CD1 nu/nu mice 
were inoculated with human U87-MG glioblastoma cells and organs were harvested 5-
6 weeks after inoculation. Adjacent coronal brain cryosections were mounted on gold- 
and ITO-coated slides for FTIR and MALDI-MSI respectively. MALDI-MS images were 
acquired in reflector positive mode using DHB matrix. For reference purposes, the 
gold-coated section used for FTIR measurement was stained with hematoxylin and 
eosin and a microscopy image was taken (Fig. 22A, left panel). As FTIR images 
feature comparatively small volumes of data, it became possible to partition the entirety 
of acquired infrared spectra into ten groups by virtue of a single (k = 10) k-means++ 
cluster analysis. In contrast to single-section segmentation, this process guarantees 
the identification of similar tissue areas across all four examined brain tissue samples. 
In this context, the cluster number k was empirically found to partition the tissue into 
additional morphology-related segments. By linking the obtained spatial properties that 
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represent inter- and intra-section dependencies between a single FTIR and H&E 
image, it became possible to locate similar cells within the other images as they share 
the same index-value. This enabled identification of the segment corresponding to 
tumor (Fig 22A, right panel) without the need of additional histochemical stains. By 
means of intensity-based registration, the spatial properties derived from FTIR image 
segmentation were used to automatically define regions of interest within the 
subsequently acquired MALDI-MSI dataset. For further analysis of tumor-related mass 
shifts, the previously identified segment that resembled tumor contours (S1) was used 
to extract region specific MS profiles.  
 
In addition, an adjoining segment (S2) which was not noticeable in the reference H&E 
image, was examined (Fig. 22A), as it may correspond to potential expansion of the 
tumor margin like an edema and/or an infiltration zone characteristic of glioma. The 
registration efficiency was quantified by calculating the DSC, which suggested an 
overlap of more than 97% (DSC = 0.982 ± 0.004) between the registered FTIR and 
fixed optical MS image (Fig. 22C). Targeted extraction of mass spectra that lie within 
the identified segments borders (Fig. 22D) was achieved by transforming the 
respective FTIR coordinates into MSI coordinates. For the identification of divergent 
mass signals that may represent segment-specific biomolecular signatures, feature 
extraction using the ROC criterion was calculated. For each segment, the ten 
m/z-values that are most suitable to distinguish between mass spectra within and 
outside the respective segment were identified (Fig. 22E). For instance, m/z 797.1 was 
identified as a signal specifically elevated in S1. The m/z feature 204.2 was linked to 
the extended tumor margin S2 and m/z 867.2 was identified as an ion that was 
symmetrically distributed across the brain.  
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Figure 22 FTIR-based targeting of tumor lesions in xenografted CD1 nu/nu mice.  Brains of four CD1 nu/nu 
mice (#1 to #4) were inoculated with 1 x 105 human U87-MG glioblastoma cells; organs were harvested 5-6 
weeks later. Subsequently, adjacent 8 µm coronal brain sections for FTIR and MALDI MS image acquisition were 
prepared. FTIR data acquired from cryosections of all four mouse brain samples were simultaneously 
disaggregated by (k = 10) k-means++ segmentation to identify intra- and inter-specimen relationships. (A) By 
comparing the depicted spatial contours belonging to a given index in a single brain section (right panel) to its 
corresponding H&E stain on gold (left panel), it becomes possible to identify tumor-associated segments in all 
four specimen because they share the same index. (B) Binary images derived from FTIR data and microscopic 
images of subsequent sections used for MS acquisition are automatically registered. The resulting fusion images 
(white = matching areas, magenta = non-matching areas) are overlaid by contours of two segments (S1, red 
& S2, green) present in all observed specimen. (C) The quality of registration is further evaluated by means of 
DSC calculation, which reveals a mean overlap of 98.2% (DSC = 0.982 ± 0.004) between all transformed binary 
FTIR images and the binary images used for MSI measurement (D). Extracting only mass spectra that lie within 
the transformed spatial contours of S1 and S2 enables identification of m/z-values with matching distribution 
patterns (m/z 797.1 tumor-specific signal in S1, m/z 204.2 as signal specific for the expanded tumor margin S2) 
by (E) means of feature selection using the area between the empirical receiver operating characteristic (ROC) 
curve and the random classifier slope. For both S1 and S2, ten conspicuous features (highlighted in red for S1 
and green for S2) were calculated. 
 
In order to verify the FTIR-denoted tumor contours that were assigned based on 
comparison to a single H&E stain, the remaining sections were also designated to 
histochemical staining (Fig. 23). Without prior knowledge about tumor occurrence, the 
calculated tumor segments were automatically registered to the corresponding 
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H&E image (DSC = 0.994 ± 0.001). In all sections, the predefined tumor contours 
precisely matched the tumor distribution of infiltrating glioblastoma cells. Moreover, the 
stain of section #2, for which nearly no (0.4%) infrared spectra were assigned to the 
tumor-associated allocation group, was proven to be cut off target and didn’t contain 
glioblastoma cells. It is uncertain whether the positively determined pixels refer to 
false-positives or small tumor residues, i.e. intra-tumor vessels. 
 
 
Figure 23 Correlation of tumor contours visible in H&E stained 
images and FTIR segments. Coronal brain sections of CD1 nu/nu 
mice engrafted with U87-MG glioblastoma cells were designated to 
subsequent FTIR image acquisition and histochemical staining. (A) 
The observed tumor cell infiltration could be linked to FTIR-derived 
image segments (B) that were automatically registered (DSC = 0.994 
± 0.001) and visualized within the respective H&E stained image, thus 
demonstrating precise FTIR-based tumor localization.  
 
After successful H&E evaluation, the intensity distribution patterns of all 20 peaks 
whose presence or absence was identified to correlate with either S1 or S2 were 
visualized in order to verify the segment contours by multiple sensor types. A match 
between the spatial properties from FTIR and all identified masses in complex MSI 
datasets could be observed, which emphasizes the authenticity of the identified tumor 
localization (Fig. 24). Moreover, FTIR-denoted segmentation was proven to add 
substantial value by identifying the tumor-related segment S2 that was not observable 
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in conventional H&E staining, but supported by multiple masses identified in 
MALDI-MSI. 
 
 
Figure 24 Distribution patterns of m/z features representing FTIR segment contours. 
Subsequent to MSI, FTIR images of four CD1 nu/nu mice brain sections inoculated with 
U87-MG glioblastoma cells were acquired and clustered for guided extraction of tumor-
associated masses that resemble tumor/margin-contours. For two segments, S1 and S2, ten 
discriminant mass peaks were identified by means of feature extraction using the empirical 
ROC curve criterion. The identified peaks not only show importance for the respective 
segment, but also resemble their spatial pattern.  
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In summary, the automated pipeline of segmentation and subsequent co-registration 
enabled precise targeting of glioma tumor areas. In comparison to conventional 
histopathology which comprises of histochemical tissue staining, FTIR-guided 
MALDI-MSI provided additional spatial tissue characterization and in-depth molecular 
profiling. In addition, the possibility to segment multiple tissues at once and thus 
circumventing the necessity of additional stains was demonstrated as linkage to a 
single H&E stain proved to be sufficient to enable tumor localization in multiple 
biological replicates. 
 
5.3.2 Automated MS marker signature retrieval for defined tissue morphologies 
Comparison of FTIR cluster images to H&E stains enables targeted annotation of 
pathologically important tissue areas such as tumor margins. However, the needed a 
priori information (i.e. the histopathological examination) is a limiting factor in clinical 
mass spectrometry. A different application of FTIR-guided MSI is the dissection and 
segment-wise comparison of mass signals. This allows for a spatially focused retrieval 
of disease-related marker signatures without the need for prior knowledge about the 
examined specimen’s structural makeup. As a suitable example, coronal cerebellum 
cryosections of NPC1 I1061T knock-in mice that resemble Niemann-Pick type C 
disease, a spatially restricted neuronal lipid disorder, were mounted on gold-coated 
object slides. In addition, sections of a C57BL/6 mouse brain were prepared at a similar 
region in order to serve as a control. FTIR images were recorded for both animals and 
subsequently portioned into five segments by means of k-means++ segmentation. In 
this context, the cluster number k was empirically found to result in comparable 
morphology-related segments in both brain tissue sections. Four segments were 
chosen in order to in-silico dissect subsequently acquired MSI datasets (Fig. 25A). 
The fifth segment was discarded as it represented each tissue’s contours. Sections 
designated to MALDI-TOF-MSI acquisition were coated with PhCCA matrix in 90% 
acetone solution to ensure optimal acquisition of negatively charged lipids and 
metabolites. In comparison to the Allen Brain Reference Atlas, the defined segments 
were linked to their morphological counterparts (Fig. 25B). Hence, (k = 5) k-means++ 
segmentation of the recorded FTIR images revealed the spatial contours of an 
unspecified microstructure (I), cerebellar granule layer (II), cerebellar fiber tracts (III) 
and molecular layer (IV). After automated intensity-based registration 
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(DSC = 0.992 ± 0.003) to the optical image used for MALDI-MSI acquisition, the mass 
signatures provided by MALDI-MSI were extracted for each individual index to allow 
for a segment-wise and therefore cerebellar substructure-wise comparison. By 
applying t-test based feature extraction, the ten m/z-values that differ the most between 
NPC1 I1061T knock-in and control mice were identified for each morphological 
structure (Fig. 25C-F).  
 
 
Figure 25 Comparison of MS lipid/metabolite signatures derived from FTIR-segmented NPC1 and Control 
mouse brains.  (A) FTIR images of coronal mouse cerebellar sections (NPC1 I1061T knock-in mice versus 
C57BL/6 control mice) were divided into four segments of maximum data similarity by k-means++ clustering. (B) 
Comparison to the Allen Brain Reference Atlas (Image credit: Allen Institute Mouse Brain Atlas [149], P56, 
Coronal, Image 121 of 132) suggests the morphological identity of three FTIR-derived segments, namely granule 
cell layer (II) fiber tracts (III) and molecular layer (IV). The remaining segment (I) represents an intermediate 
region between the outer edge of the arbor vitae and the granule cell layer. The spatial contours reflecting distinct 
cell morphologies were automatically registered to the optical image used for reflector negative MSI acquisition, 
thus enabling extraction of the respective mass signatures. Comparison between the MS lipid/metabolite profiles 
of NPC1 and C57BL/6 mice guided to the obtained infrared segments was achieved by means of t-test based 
feature extraction (C-F) The mean intensity of ten distinct masses allowing for discrimination between healthy 
and diseased mice was visualized for each predefined cerebellar substructure. 
 
Most of the received marker signals were found to differ between segments, which 
leads to the presumption of locally restricted lipid accumulation. The highest similarity 
was observable between the molecular layer and the observed unspecified 
microstructure that share five common features of which three are m/z 806.6 and its 
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potential isotopes m/z 807.6 and m/z 808.6. In NPC1 |1061T knock-in mice, the 
molecule of m/z feature 1136.9 was found to be up-regulated within the cerebellar fiber 
tract and concurrently down-regulated in the granule cell layer. In this context, the 
achieved morphological breakdown derived by FTIR segmentation enables the 
identification of local mass shifts that would otherwise balance out over the entire 
dataset. In this regard, by comparing the obtained results to the mouse model-
describing literature [131], the granule cell layer-specific accumulation of m/z 1382.9 
and its potential isotope m/z 1383.9 become particularly interesting (Fig. 26A), as it 
may refer to the previously reported disease-related ganglioside GM2 (d18:1/18:0). An 
argument against this hypothesis is the mass-difference of 0.2 Da when compared to 
previous mass spectrometry analyses of GM2 (d18:1/18:0) [158]. For further 
evaluation, the granule cell layer-specific increase of m/z 1382.9 was monitored in 
subsequent sagittal brain sections of NPC1 |1061T knock-in and C57BL/6 control 
mice. Fold change plots (Fig. 26B) of the mass features acquired within the sagittal 
cerebellar granule layer were created in Tableau (Tableau Software Inc., Seattle). The 
obtained data confirmed the identification of a locally-restrictive accumulation that is 
not noticeable without prior morphology-guided dissection.  
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Figure 26 FTIR-guided identification of NPC1-related locally-restricted GM2 accumulation  
(A) The distribution and accumulation of m/z 1382.9 was monitored within cerebellar brain sections of 
NPC1 |1061T knock-in and C57BL/6 control mice. The mass was previously identified as a potential 
discriminant marker in granule cell segments denoted by FTIR imaging. (B) Comparison of the fold 
change between mass spectra originating from the entire section and mass spectra exclusively 
originating from the granule cell layer demonstrates the added value of prior FTIR dissection. 
 
In conclusion, the obtained results suggest that, without the need for H&E staining, 
FTIR image-based tissue segmentation and segment-wise comparison of MS data 
allow for unbiased extraction of distinguishing features. The presented workflow is fully 
automatable.  
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5.3.3 Identification of GIST by means of FTIR cluster analysis 
An essential and challenging task for the identification of diagnostic markers in mass 
spectrometry imaging is the occurrence of histological heterogeneities. , as the cellular 
origin of acquired mass signatures is uncertain without annotation. For this reason, it 
has become common practice to utilize subsequent H&E stained sections and 
pathological guidance in order to define striking tissue regions of similar morphological 
makeup. However, the manual assignment in current praxis makes it impractical for 
the analysis of large tissue cohorts. In this context, recent publications have 
demonstrated direct cluster analysis of MSI data in order to de novo identify 
heterogeneities and tumor-subpopulations in breast and gastric cancer [159, 160]. 
Moreover, linkage between intra-tumor segments that are a priori not observable by 
conventional histopathology and disease outcome has been presented [118, 161]. The 
depicted studies reflect the high potential of unsupervised discovery of tissue 
heterogeneities. However, size and complexity of ultrahigh-resolution MALDI-MSI data 
(especially when using a FTICR detector) makes clustering of large sample cohorts 
impractical and demands for excessive pre-processing and dimensionality reduction. 
In contrast, FTIR images are of comparably small size which makes it possible to 
virtually micro-dissect a multitude of tissue sections in a faster and computationally 
less expensive fashion when compared to MALDI-MSI (chapter 4.1.4.). Moreover, the 
derived information about intra- and inter-sample dependencies can automatically be 
transferred to MSI in contrast to manual histopathological annotation. In order to 
examine histological heterogeneity in a suitable test case of clinical relevance, three 
series of 89 fresh-frozen tissue samples derived from 27 patients suffering from GIST 
were cut to 8 μm thickness and mounted on gold-coated object carrier slides. FTIR 
images of all specimens were acquired at 25 μm spatial and 8 cm-1 spectral resolution. 
Sectioning and infrared measurements were performed over the course of multiple 
days to balance out practical and technical variability. For later histopathological 
reference analytic, subsequent tissue sections were placed on Starfrost adhesive 
slides. H&E staining was performed by research assistants at the Pathology Institute 
of University Medical Center Mannheim, and optical reference images were acquired 
using an Aperio CS2 Scanner. In order to identify tissue heterogeneity in an 
unsupervised fashion, processed FTIR images were grouped by means of k-means++ 
cluster analysis. It was assumed that related morphologies would display similar 
vibrational properties across all patients. For this reason, segmentation was 
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simultaneously performed across sections on a total number of 1231560 MIR-spectra. 
As the true number of occurring tissue morphologies was unknown, segmentation was 
performed with different k-values in the range of 3-10 (k = 5 exemplified in Fig. 27A). 
Thereby, calculation and spectral allocation was rapidly performed in ~90 seconds 
resulting in a color-coded pattern of inter- and intra-tumor dependencies. In this 
context, heterogeneities could be observed in almost all examined tissue sections. 
However grouping was possible, as the prevalent color remained mostly consistent 
within section series of the same patient recorded on different days. Hence, sections 
of patient A, AA, AB, C, G, J, M, N, O, U, W and Z were assigned to belong to the 
same allocation group “red” and patient E, L, Q, R, S and Y were assigned to “purple”. 
Similarly, patient D, G, X and T who underwent surgery an additional time after tumor 
relapse were assigned to “blue”, patient I, K, P and V to “green” and patient B and Lto 
“yellow”. Differences between sections derived from the same patient were observed 
in AA, E, J, W and Y for which allocation changed between the red and purple segment 
and V for which two section was assigned to “green” and one section was assigned to 
“yellow”. In order to assess the corresponding morphological characteristics, the 
respective samples were linked to clinical metadata (Supplement Table) and 
annotated subsequent H&E stains (exemplified in Fig. 27B). It turned out that the red- 
and purple-colored segments represent tumor areas, whereas the blue-colored 
segment corresponds to the occurrence of fibrosis and edema. The green allocation 
group could be correlated to adipose tissue in patient I and necrosis in patient P and 
K. In patient A, the green-allocated residue represented normal liver tissue. The 
remaining yellow-colored segment was found to correspond to sectioning artifacts like 
folds and freezing damage.  
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Moreover, it turned out that the tumor origin might influence segmentation, as the tissue 
sections of the blue-coded patients B, D, F, T and X were all resected out of the colon. 
However, no such correlation was observable for sections derived from other organs. 
Furthermore, a hematoma observed in the liver section of patient G also perfectly 
matched the blue-allocated pixels in that section. (Fig. 27B). Although the red- and 
purple-colored segment resemble the annotated tumor regions in all samples, a 
relation to different mutation subtypes of GIST was not observable, as all red and 
purple sections were genetically distinct.  For example the spectra derived from patient 
C and Z were clustered similarly, although the tumor of patient C features a mutation 
of c-KIT in exon 9, whereas the tumor in patient Z features mutations in exon 11 and 
13 as well as a mutation in exon 18 of the PDGFRα gene. It can therefore be concluded 
that FTIR image segmentation is suitable to identify dense tumors in large sample 
cohorts in a fast and computationally inexpensive fashion. The presented subgrouping 
of patient-derived tissues could serve as a prescreening in order to guide subsequent 
MALDI-MSI examination. As the prior selection of “pure” cell groups of similar 
molecular makeup is a necessary condition for the identification of biomarkers, the 
method can be used to boost classification efficacy [162]. Moreover, differentiation and 
segmentation can be performed without the need of any a priori information, except 
the number of expected tumor subpopulations k. In that regard, the depicted example 
of k = 5 segmentation appears inappropriate, as the resulting red and purple segment 
do not correspond to divergent histological features. In order to identify diagnostic 
features that reflect tumor subpopulations and patient outcome, an increased chemical 
specificity as provided by mass spectrometry would be necessary.  
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5.4 Same-slice targeted FTIR-guided FTICR-MS acquisition 
Extraction of mass features targeted to pre-defined tissue morphologies and/or 
divergent cell populations by means of FTIR segmentation improves the interpretation 
and characterization of MALDI-MSI data in an unbiased and histopathology-
independent manner. As a negative side effect, the integration of FTIR images 
prolongs the experimental acquisition time and induces additional data load. This is 
especially unfavorable in a clinical setting in which speed and ease of a technique are 
necessary for its applicability. For this, the analysis of large tissue series typically 
demands a compromise between resolution and throughput in order to keep data load, 
acquisition time and computational cost manageable. In addition, only a small, 
manually-defined fraction of the recorded MSI data is actually used for later 
characterization [21]. To this end, it becomes obvious that the pre-definition of spatially 
restricted morphological structures for target-exclusive MALDI-MSI measurements has 
the potential to drastically increase throughput. FTIR images are beneficial as their 
acquisition only takes a fraction of time when compared to MSI, especially ultra-high 
resolution MSI. Moreover, segmentation of FTIR images provides guidance to 
predefined tissue morphologies without the introduction of user bias. In order to 
overcome the computational and practical challenges related to ultrahigh-resolution 
MS, the developed workflow was modified to allow for automated acquisition of FTIR 
and ultrahigh-resolution MALDI-MSI images using a FTICR-MS (Fig. 28). Moreover, 
the use of gold-coated object slides enables multimodality imaging on the same tissue 
section and thus guarantees the needed precision for high-resolute registration and 
morphology definition.  
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Figure 28 Schematic workflow diagram for FTIR-guided single-slice acquisition of MSI data. FTIR image 
acquisition on gold can be utilized to denote measurement regions and/or ROIs prior to MALDI-MSI acquisition 
from the same slide. The spatial contours are defined by segmentation of the FTIR image and subsequent 
registration to the optical image used for later MSI measurement. By choosing a particular segment, its respective 
MSI contour points can be calculated in order to modify the MSI acquisition file. The presented workflow enables 
unbiased targeted mass feature extraction and multimodal acquisition of the same tissue specimen, thus 
guaranteeing optimal registration. 
 
Most importantly, transfer of FTIR-derived spatial information to the FTICR mass 
spectrometer before MSI acquisition enables the exclusive measurement of a pre-
defined number of segments in subsequent MALDI-FTICR-MSI. In order to examine 
the capabilities of this new workflow, coronal and sagittal brain sections of C57BL/6 
wildtype mice were prepared for FTIR- and subsequent MALDI-FTICR-MSI 
measurement. PhCCA in 90% acetone solution was used as a matrix to enable optimal 
crystallization and recording of lipid and metabolite signals in reflector negative mode. 
Utilizing FTIR image-based k-means++ segmentation, MALDI-FTICR-MSI 
measurements were directed at morphological structures of interest, namely the 
dentate gyrus of the hippocampus in the sagittal mouse brain section and the 
cerebellar fiber tracts in the coronal section. Targeted MALDI-FTICR measurement of 
the dentate gyrus was achieved by partitioning the respective FTIR image into eight 
segments (Fig. 29A). After successful registration (DSC = 0.99), masses were 
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recorded using a common 512kB data point size (Fig. 29B). The resulting image was 
acquired in 24 min, which indicates a reduction of 97.8% compared to an acquisition 
time of 18.2 h for the whole tissue section (Fig. 29C). Accordingly, the data volume of 
the whole tissue section was reduced from 35.3 GB to 0.7 GB. MALDI-FTICR 
measurement of the fiber tracts in coronal brain sections was achieved by subdividing 
the respective FTIR image into five segments (Fig. 29D). After registration to the 
optical image used for MSI (DSC = 0.992), cerebellar fiber tracts were exclusively 
measured using a more excessive 4M data point size (Fig. 29E) that resulted in a total 
data load of 189.5 GB. This implies a reduction of 79.3% when compared to 
whole-tissue image acquisition that would have resulted in a total data load of 
915.3 GB (Fig. 29F). Similarly, the data acquisition time was reduced to 15.4% from 
25.4 hours down to 3.9 hours. In both test cases, the cluster number k was gradually 
increased until the desired morphological sub-region became observable. 
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Figure 29 FTIR-guided, spatially restricted data acquisition by ultrahigh-resolution 
MALDI-FTICR-MSI (A) Based on a FTIR-image of a sagittal CB57BL/6 brain tissue section, 
segments were calculated by means of (k = 8) k-means++ cluster analysis. (B) The segment 
that represents the spatial contours of hippocampal dentate gyrus was picked and registered to 
the optical image used for subsequent ultrahigh-resolution MALDI-FTICR-MSI, thus enabling 
targeted segment-exclusive recording of mass features. The depicted example image of 
m/z 1133.64 (± 0.05) was acquired in reflector negative mode after matrix coating with PhCCA 
in 90% acetone solution. (C) Targeting of the dentate gyrus region using a common 512k data 
point size drastically decreases (97.8%) data load and admission time. (D) In a similar fashion, 
the coronal brain tissue section of a CB57BL/6 mouse was dissected into five segments to 
enable targeted acquisition of the cerebellar fiber tracts. (E) The depicted intensity distribution 
of m/z 906.61 (± 0.05) was acquired in reflector negative mode using a more excessive 4M data 
point size, thus (F) reducing data load and acquisition time by 79.3%. 
 
Ultimately, time saving and data load decrease are determined by the size of the 
respective segment used for acquisition. In conclusion, the potency of FTIR-guidance 
to drastically improve throughput and data handling of ultrahigh-resolution MSI was 
demonstrated using a Bruker Daltonics MALDI-FTICR-MSI system.  
Discussion 
81 
6 DISCUSSION 
In this thesis, a robust workflow that combines the speed and ease of vibrational 
spectromicroscopy with the in-depth chemo-analytical capabilities of mass 
spectrometry imaging was developed. Instead of combining the obtained spectral 
features in order to potentially discriminate between different cell populations with 
higher accuracy, a multimodal guidance approach was investigated in which FTIR 
imaging guides the interpretation and acquisition of subsequent MSI experiments. In 
this context, a variety of (semi-)automated methods for the targeted extraction and 
acquisition of mass signatures was evaluated.  
 
6.1 Technical evaluation of FTIR and MS imaging 
A major part of this work focused on the development and evaluation of an automated 
workflow that enables combinatory FTIR-MS multimodality imaging. With respect to 
the work of Wehbe et al. [145], the first challenge during development was the 
evaluation of different coating-materials and their influence on MS and FTIR imaging. 
In case of FTIR, imaging of homogeneous porcine liver sections use using ITO-coated 
slides that represent state-of-the-art material for MS image acquisition was proven to 
significantly impair spectral quality and dispersion when compared to slides coated 
with gold or Ag/SNO2 [146, 147].. For this reason, ITO was considered impractical for 
vibrational imaging, although FTIR-based segmentation results were comparable. In 
case of MSI, no critical differences between gold- and ITO-coated object carriers were 
observable. In comparison to ITO, signal intensity of mass spectra acquired on porcine 
liver sections was slightly increased when obtained on gold. However, as the improved 
signal was accompanied by increased scattering, the influence of different conductive 
slide-coating materials on MS imaging remains uncertain. MS imaging on MirrIR-slides 
was not evaluated, as the slides didn’t fit into the target plate holder of the mass 
spectrometer and no compatible replacement was found. Taken together, these 
findings don’t impede the usage of ITO-coated object slides for parallel acquisition of 
FTIR and MS images, but same-slide measurements appear unfavorable. In 
comparison to gold-coated carriers, ITO- and MirrIR-slides hold the advantage of being 
transparent and thus allow for histopathological staining following MALDI-MSI and 
FTIR imaging measurements. By contrast, gold can be utilized for both imaging 
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modalities and thus enables subsequent FTIR- and MS-image acquisition on the same 
specimen. This represents a significant advantage for multimodality imaging purposes 
by further improving registration efficiency [19, 21].  
 
Besides practical considerations necessary for the realization of combinatory MS-FTIR 
imaging, a conceptual strategy had to be thoroughly investigated. In this sense, two 
major strategies for multimodal imaging exist. The former combines the orthogonal 
information obtained from different sensor types or acquisition modes to create 
hyperspectral data that allows for joint analysis and a deeper insight into the chemistry 
of complex samples [13, 163]. The later utilizes the sensor-dependent capabilities of 
one modality for the purpose of improving or guiding another downstream modality [14, 
20, 164]. In this work, the segmentation and classification capabilities of MS and FTIR 
imaging were investigated. In this context, FTIR-based segmentation of glioblastoma 
xenograft tissues and human-derived GIST was proven superior when compared to 
MALDI-MSI, as the respective tumor contours were depicted with higher accuracy. 
Advanced state-of-the-art clustering algorithms improved the dissection of MSI data 
sets when compared to the k-means++ method and thus indicate that proper clustering 
of MSI is possible [144]. However, the FTIR-derived structural information connote a 
significant improvement. In order to extend the capabilities of MSI-segmentation, a 
variety of segmentation pipelines have been presented in recent publications 
(reviewed in [165]). In a comparative study of Sarkari et al., enhanced MSI 
segmentation was presented by applying prior dimensionality reduction and alternating 
distance metrics [166]. Widlak et al. demonstrated unsupervised iterative k-means 
clustering of squamous cell carcinoma by including a Gaussian mixture model in order 
to detect spectral components [167] and Bemis et al. examined the potency of 
probabilistic segmentation by applying spatial shrunken centroids [168]. Moreover, the 
applicability of dimensionality reduction techniques such as PCA and t-SNE to 
visualize structures in MSI data was examined [169]. Despite these findings, 
FTIR-based tissue segmentation holds major advantages. The technique is unaffected 
by ion suppression, analyte-diffusion or other effects that may suppress the 
identification of morphology-dependent differences. Moreover, the technique operates 
comparatively fast at higher spatial resolution and demands for no excessive 
processing. The feasibility to record FFPE tissue materials was also demonstrated, 
although segmentation failed to identify tumor areas in human-derived prostate cancer 
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sections. It is uncertain, if this is due to the noise increase caused by embedding 
medium residues or if FTIR segmentation is in general not able to visualize cancer in 
this particular tumor type, as more comprehensive studies of different tissue types 
would be needed. The presented long-term experiments demonstrated high stability 
and technical reproducibility of FTIR-denoted tissue segmentation. In that sense, the 
establishment of a tissue databases for quality control purposes appears to be 
possible. The non-destructive nature of FTIR microscopy makes it also applicable prior 
to MSI, thus providing structural information prior to MSI acquisition. However, FTIR 
lacks the ability to directly visualize individual molecules in a multiplex manner which 
makes its combination with mass spectrometry expedient. Taken together, these 
considerations indicate for the potency of guided multimodality imaging that utilizes the 
rapid virtual dissection of tissues obtained from FTIR imaging to define homogeneous 
cell populations in subsequent MSI experiments.  
 
6.2 Development of FTIR-guided MSI 
According to the depicted single modality results, a workflow for FTIR-guided, 
ultrahigh-resolution MSI was developed that offers interpretation and data acquisition 
focused on defined tissue sub-compartments independent of histopathological 
staining. This represents a substantial advance when compared to previous image 
fusion approaches that rely on H&E images acquired on adjacent sections for 
interpretation [14, 18, 21]. The ability of infrared spectroscopy to visualize different 
classes of biomolecules provides a particularly powerful tool for the analysis of tissue 
samples as traditional histology is only able to visualize a few molecules 
simultaneously [170]. The presented concept for multimodal imaging can be easily 
transferred to any other non-destructive optical upstream modality (i.e. Raman 
imaging), thus providing guidance in cases where FTIR imaging is incapable of 
identifying tissue regions of interest. Spatially guided imaging is applicable to MSI data 
obtained using any ionization method and mass spectrometer (i.e. DESI-MSI). The 
only requirement is the alignment of both imaging planes onto the same coordinate 
system for which a registration routine was developed in MATLAB. Thereby, the 
acquired FTIR image and the optical image used for MSI acquisition are transferred to 
binary and subsequently registered. 
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6.3 Tumor targeting and spatially restrictive mass feature identification 
Integration of the molecular information provided by MALDI-MSI and tissue anatomical 
structures that can be resolved by microscopy is mandatory for its clinical 
implementation. Utilizing spatial features derived from FTIR imaging, the precise 
identification of tumor-associated contours was presented in mouse brain sections 
inoculated with human U87-MG glioblastoma cells. This was achieved by joint 
clustering of all acquired mid-infrared images at once, as it reveals cellular intra- and 
inter-section dependencies. For this reason, the linkage between a single 
segmentation image and its corresponding H&E stain sufficed to enable tumor 
localization in all biological replicates. In contrast to MSI, clustering of FTIR data 
acquired for multiple sections was easily performed without the need of excessive 
preprocessing. In order to extract tumor-specific mass signatures with increased 
precision, regions of interest were defined by registering the retrieved tumor-segments 
to MSI space. The registration quality was quantified by calculating the DSC that 
suggested a precise alignment between FTIR image and MSI data set 
(DSC = 0.982 ± 0.004). Whereas the capability to visualize sparse tumor populations 
might represent a challenging task, automated segmentation and registration of tumor-
lesions was readily performed. In addition to tumor-contours, molecular differences 
were observed in an expansion of the tumor margin (referred to as the ‘S2 segment’). 
Both the retrieved distribution pattern of glioblastoma and altered surrounding tissue 
were backed up with chemical mass features. These observations emphasize the 
potency of FTIR-imaging to reveal molecularly substantially altered cell populations 
that are invisible to conventional H&E staining. In order to further characterize the 
segment, additional histopathological and/or in-depth mass spectrometry techniques 
such as tandem mass spectrometry may be considered. Without further knowledge, 
the hypothetical origin of the S2 contour might be a brain edema caused by the 
inoculation and/or a glioma-characteristic infiltration zone. It is also possible that S1 
and S2 refer to the glioblastoma-characteristic necrotic tumor center and surrounding 
anaplastic cells. 
 
It is noteworthy that the identification of U87-MG xenograft patterns in mice represents 
a simplified test case in comparison to clinical human-derived glioblastoma biopsy 
analysis. On top of this, the origin of U87-MG was critically scrutinized by Allen et al. 
in a recently presented study [171]. Based on genetic profiling and transcriptome 
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analysis, they discovered that the DNA profile differed from the cells originally isolated 
by J. Ponten and associates from 1966 to 1969. However, the automatic alignment 
between FTIR and MSI holds great promise as the mapping of data from different 
sensors to the same coordinate space allows for an improved biomolecular profiling of 
the examined specimen. Moreover, the structural annotation provided by FTIR 
segmentation enables the extraction of mass features in context of their anatomical 
localization and mitigates the lack of a priori information that mass spectrometry 
laboratories often deal with.  
 
6.4 Automated screening for local mass biomarker signatures 
In the course of this work, a method that utilizes segmentation of FTIR images in order 
to explore tissue morphologies in MSI data was developed. Serving as a suitable 
example, lipid disorders were examined in mouse brain, arguably one of the most-used 
models to investigate human neurological diseases [172]. The technique was able to 
identify spatially restrictive mass signature shifts between NPC1 and wild-type mice by 
using the FTIR-denoted anatomical structures as a template for pairwise feature 
extraction. This way, disease-related effects could be associated to distinct brain 
regions without any a priori information about their spatial occurrence. In comparison 
to the ABA the origin of three segments could be identified, namely cerebellar fiber 
tracts as well as granule and molecular cell layer. In addition, an intermediate region 
between white and grey matter was identified. Although the morphological origin of this 
structure is unknown, it was repeatedly observed in FTIR images acquired throughout 
the course of this thesis. The most likely reason for its occurrence is the partly 
acquisition of granule cells and myelinated axons in a single pixel. As the infrared 
signatures of the granule cell layer and the cerebellar fiber tract differ considerably, 
mixed signals have the potential to form a distinct cluster during segmentation. This 
hypothesis is supported by two observations. First of all, the structure’s calculated 
thickness mostly amounts to a single pixel (25x25 μm) which could account for the 
fuzzy intersection between grey and white matter. Secondly, a similar border region 
was obtained at the outer edge of the tissue. The respective segment was discarded 
prior to the analysis, as it is conceivable that it represents the intersection of spectra 
acquired on- and off-tissue.  
Discussion 
86 
Notwithstanding the above, the presented technique substantially improves MSI 
analysis by predefining cerebellar sub-sections. This way, the local accumulation of 
distinct masses, such as m/z 1382.9, which was insignificant over the entire dataset 
became detectable. This particular mass might refer to the previously reported 
accumulation of GM2(d18:1/18:0) although the reported mass differs [131, 158]. This 
allows for two possible explanations: Either the depicted m/z 1382.9 refers to a different 
molecule that has not been reported in the mouse model-describing literature or the 
mass axis was misaligned during the presented MS experiment. Future 
ultrahigh-resolution MSI experiments will further investigate the origin chemical identity 
of m/z 1382.9. 
 
Biomedical MSI is typically not feasible for intraoperative applications and therefore 
carried out in analytical laboratories for which tissue annotation is a major bottleneck. 
The automatic alignment and dissection of MS data into subsections facilitates 
comparative studies of structured organs (e.g. brain, kidney) or infiltrating tumors of 
different origin. On the negative side, it doesn’t improve comparative analysis of 
homogeneous specimen (e.g. liver sections). It is noteworthy that the presented spatial 
decomposition occurs solely at data level and can therefore be adjusted should the 
initial experiment fail to detect sub-structures of interest. For this reason, FTIR-guided 
dissection holds decisive advantages when compared to disruptive procedural steps 
such as laser-capture microdissection that are irreversible [20, 164]. In addition, joint 
segmentation of multiple images would guarantee the comparative analysis of inter-
section compartments with a similar morphological composition, thus circumventing 
the need for atlas linkage [173]. 
 
6.5 Assessment of histological heterogeneity  
A major challenge in (pre)clinical mass spectrometry imaging is the occurrence of 
histological heterogeneities. The occurrence of morphological differences impedes 
true molecular marker identification by introducing variability and mixed class data 
sets. Without precise information regarding the identity of each acquired signature, it 
is highly possible that tumor-related signals are overlooked. For mass spectrometry, 
the conventional approach of integrating histopathological tissue stains can prove to 
be insufficient [21, 97, 174, 175], as they demand for manual annotation and are thus 
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not automatable. Moreover, the unbiased exploration of alterations demands for an 
untargeted analysis technique that accounts for the spatial tumor environment. In order 
to solve the issue, direct segmentation as well as t-SNE dimensionality reduction and 
color-coding of MSI data have been presented [118, 159, 176]. Thereby, 
heterogeneities and subpopulations were identified de novo in breast and gastric 
cancer and tumor-types that were not distinguishable by conventional histopathology 
could be linked to disease outcome prognoses [118, 159-161]. Despite the reported 
potential of direct MSI dissection, this method has major disadvantages. In a practical 
sense, size and complexity of MALDI-MSI data (especially ultrahigh-resolution MSI 
using a FTICR detector) makes unsupervised clustering of large sample cohorts 
impractical and time consuming as it demands for excessive pre-processing. 
Moreover, the high information content of MSI data is not necessarily beneficial for 
segmentation purposes as the high dimensionality introduces multiple challenges. 
Although some dimensions (mass features) are characteristic of a given subgroup, a 
larger number of attributes will usually not be meaningful and can mask existing 
clusters in high-dimensional data sets [177, 178]. Furthermore, it is likely that the 
disease-related effects are depicted in multiple mass features. This presents a 
challenge as samples should only be grouped together if they exhibit a common 
correlation among the respective set of m/z-values. The phenomenon that different 
features or correlations may be relevant for varying clusters is called local feature 
relevance. Lastly, pattern recognition from a finite number of data samples in high-
dimensional feature space suffers from what is called “Curse of Dimensionality”, where 
the concept of distance substantially loses precision and consequently degrades the 
predictive power of the classification models [112].  
 
In comparison to MSI data, FTIR images are of comparably small size which allows for 
the joint segmentation of a multitude of tissue sections in a faster and computationally 
less extensive fashion. For example, FTIR-based segmentation of 89 GIST-patient 
derived tissue samples was carried out in ~90 seconds on a standard desktop 
computer. In that regard, the technique may hold great potential as a supporting tool 
in clinical MSI rather than a contender, as the identified group’s origin was mostly linked 
to the occurrence of tumor or fibrosis. In order to identify diagnostic features that reflect 
the tumor’s genetic variance and patient outcome, the chemical specificity of mass 
spectrometry would be necessary. Nevertheless, joint FTIR-segmentation of tissues 
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offers fast initial subgrouping of large tissue cohorts and can pre-select tumorous areas 
prior to MSI acquisition and mostly independent of H&E staining. The obtained 
allocation information can contribute to in-depth mass feature analysis in two ways. 
First and foremost, it becomes possible to pre-select samples of similar morphological 
composition, thus reducing the locale feature relevance and boosting subtype 
identification in MSI [162]. Secondly, FTIR-based dissection can be utilized to identify 
tissue inhomogeneity prior to MSI, thus minimizing subgroup-irrelevant spectra that 
reduce classification efficacy.  
 
6.6 Targeted spatially-restrictive high-resolution MSI acquisition 
Lastly, FTIR-denoted, segment-exclusive MALDI-FTICR-MSI was showcased as a 
way to overcome the compromise between spatial and spectral resolution needed for 
high-throughput measurements. The technique also enables the exclusive processing 
of similar cell populations, thus reducing data variance when compared to whole-organ 
images. These aspects are beneficial for very specific analyses of tissue structures, as 
time and data savings are achieved by discarding the pixels of all remaining sections 
before acquisition. Although the selection of an appropriate segment for further in-
depth mass spectrometry experiments requires knowledge regarding its location, 
shape or spectral composition, the presented workflow is independent of conventional 
histopathological staining. This represents a substantial advance when compared to 
previously reported solutions [19, 21], as the acquisition of spatially-restrictive regions 
solely relies on unbiased FTIR image segmentation results. In addition, the results of 
this thesis have emphasized the advantages of FTIR-based image dissection when 
compared to conventional histopathological stains. First and foremost, MIR-spectra 
contain additional biomolecular information that enables a more detailed differentiation 
of cells. Secondly, the use of gold-coated object slides enables FTIR image acquisition 
of the same tissue specimen prior to the MSI experiment. Same-slice acquisition 
represents a significant upgrade by further improving registration efficiency when 
compared to consecutive section registration. Moreover, same-slice measurements 
minimize practical deficiencies that can be caused by sectioning artifacts such as tears, 
strains and folds. This is essential for the exclusive acquisition of smaller tissue 
compartments, i.e. the granule cell layer of the dentate gyrus, as small misalignments 
can cause the subsequent MSI acquisition to miss the desired region. However, 
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preparation and acquisition on gold-coated slides also produces disadvantages, as the 
opaque surface limits the applicability of subsequent same-slice stains and 
microscopy. Moreover, the use of gold introduces additional costs when compared to 
ITO. For these reasons, MirrIR-slides of MS-compatible size might be better suited for 
multimodal FTIR-guided MSI depending on their conductive property. Although 
Ag/SNO2 has been reported to possess excellent electrical and mechanical qualities 
[179, 180], the exact coating-composition of MirrIR-slides is unknown and its effect on 
MSI has not been evaluated in the course of this thesis.  
 
The capability to automatically identify and exclusively acquire small-sized tissue 
compartments is ultimately denoted by the guiding optical modality and cluster 
algorithm. In this work, FTIR-guided high-resolution MSI was demonstrated using a 
Bruker Daltonics MALDI-FTICR-MSI system. However, the presented workflow is 
vendor-neutral and applicable to any subsequent imaging technique that allows to 
define measurement regions prior to recoding – be it by courtesy of an optical image 
or point definition within a vendor-specific acquisition file. The presented concept for 
multimodal imaging can be easily transferred to any other non-destructive optical 
modality (i.e. Raman imaging), thus providing guidance in cases where FTIR imaging 
is incapable of identifying the structure of interest. In addition, the workflow is 
applicable to MSI data obtained using different ionization methods and/or mass 
analyzer (i.e. DESI-MSI). The only requirement is the alignment of both imaging planes 
onto the same coordinate system. In summary, the presented technique for 
multimodality imaging bypasses computational and practical challenges in cases 
where either the region of interest only represents a comparatively small tissue fraction 
or the acquisition of whole-tissue sections is not feasible. In a similar fashion, the 
technique can be utilized to better focus high spatial and mass resolution analyses by 
limiting acquisition to morphological structures of high spectral homogeneity. 
Multimodality imaging of the same tissue slide is especially advantageous as it 
circumvents structural dissimilarities between subsequent sections and artifacts 
caused by tissue handling, such as stretches, tears or folds. In addition, it renders the 
need for additional tissue preparation steps unnecessary, which speeds up the 
workflow. On the negative side, the region-specific recording of mass data limits 
retrospective analyses and requires the region of interest to be known in advance.  
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6.7 Different cluster approaches 
The current work has focused on k-means++ clustering for its potential to rapidly 
segment complex data and therefore increase the throughput of subsequent 
ultrahigh-resolution mass spectrometry analysis. Although k-means++ represents an 
advantageous technique that can partition big data sets at a low cost of central 
processing unit (CPU) load, it also features several disadvantages. The specified 
number of computed segments k needed for clustering represents a remaining source 
of user-bias. In most experiments, the true number of identifiable tissue sub-structures 
is unknown and it is therefore up to the experimenter to determine a fitting value. 
However, this process creates two particular risks, as k-means++ represents a hard 
cluster technique that strictly allocates each pixel to one group only. If k is chosen too 
low, structures of importance might be overlooked. If k is chosen too high, the image 
is forcefully partitioned into sub-compartments that do not represent real structures, 
thus creating noise. This issue is reinforced by the fact that tissues of identical origin 
do not necessarily share a common number of mid-infrared sub-structures, which limits 
the applicability of organ-specific k-values. There are two specific reasons for this 
problem. First, tissues of the same organ can still vary in their composition, depending 
on the cutting side and disease-related effects. Second, folds and other sectioning 
artifacts typically represent separate segments, as the increased tissue thickness 
substantially alters the acquired mid-infrared spectrum. In this work, a possible solution 
that might mitigate the k-bias was proposed by applying cluster evaluation methods, 
i.e. the presented Calinski-Harabasz criterion [125] or the Davies-Bouldin index [181]. 
However, the CHC was found to be sometimes inappropriate to define a k-value that 
represents the true number of within-tissue morphologies. In multiple cases throughout 
this study, the most stable number of allocation groups was too low and cell 
populations that could be verified in H&E were only visible for manually increased k-
values. For this reason, multiple k-values were tested in many of the depicted studies 
and empirically evaluated. It is up to additional experimental testing to verify the 
accuracy of cluster evaluation techniques in order to pre-define a suitable k-value for 
tissue segmentation. 
 
An additional limitation of k-means++ is the strict partitioning of the acquired image. 
Each obtained spectrum is assigned to exactly one cluster without overlapping. In 
biology however, it is conceivable that a given cell or cell population is representing 
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multiple characteristics simultaneously. In that sense, alternative segmentation tools, 
i.e. agglomerative hierarchical cluster analysis [182, 183] that is independent of the 
value k or fuzzy c-means [184, 185] that allows each data point to belong to multiple 
clusters, could enable a more detailed and independent coverage of tissue areas. 
However, hard clustering is essential for segment-exclusive MSI acquisition. For the 
technical implementation, it is of importance to denote the exact coordinates of all 
acquired pixels, as partial recording is not possible. Moreover, the depicted alternate 
algorithms demand for additional CPU load which minimizes throughput.  
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7 SUMMARY AND OUTLOOK 
Mass spectrometry imaging provides ultrahigh-resolution mass information needed to 
uncover molecular features and heterogeneities related to the disease-state of tissues. 
The technique holds great potential in cancer research and patient personalized 
medicine, as it has demonstrated its ability to uncover tumorous cell populations and 
disease-related effects. Modern ultrahigh-resolution mass analyzers (i.e. FTICR) have 
greatly increased cell-profiling accuracy at the cost of ever increasing data load. For 
this reason, a major challenge that impedes routine clinical implementation to date has 
been the identification of regions of interests within the highly complex datasets. 
Analysis of large tissue cohorts typically demands prior histopathological annotation, 
in order to keep data load and acquisition time manageable. In contrast, the speed, 
simplicity and non-perturbing nature of vibrational microscopy has made it a valuable 
tool to complement current histopathological practice. The technique provides a rough 
overview of biomolecular distribution patterns under native conditions, but lacks MSI’s 
potential to identify specific molecules. Therefore, the development of a multimodal 
imaging workflow that combines both technique’s capabilities while overcoming 
modality-dependent restraints would have substantial impact on future research and 
perhaps clinical practice.  
 
For these reasons, this thesis focused on the following four objectives:  
1.) Evaluation of suitability of different slide-coating materials for FTIR and MS 
single modality imaging. 
2.) Development and technical evaluation of an automated workflow that 
enables combined FTIR and MALDI-MSI tissue analysis. 
3.) Application of this technique for the discrimination of healthy and diseased 
tissues in various disease models. 
4.) Use of FTIR-guidance in order to pre-define acquisition regions in 
subsequent MALDI-MSI experiments, thus reducing data load and 
acquisition time.  
 
In the first part of this study, different coating materials were tested for their applicability 
in FTIR and MS imaging. Thereby, it could be shown that the respective composition 
had a substantial influence on spectral quality in both modalities. For FTIR imaging, 
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gold- and Ag/SNO2 (MirrIR)-coating provided superior spectral quality and less 
dispersion on homogeneous liver tissue samples when compared to ITO. For MSI, the 
use of gold- and ITO-coated slides resulted in comparable mass signatures and 
dispersion. MirrIR-slides could not be used for mass spectrometry as they didn’t fit into 
the Bruker instrument. For these reasons, multimodal experiments were carried out on 
gold-coated slides. Moreover, the feasibility of long-term FTIR studies and 
measurements of FFPE tissues was briefly evaluated.  
 
In the second part of this study, a concepts for guided multimodality imaging was 
developed. In this context, FTIR image segmentation was able to identify tissue 
structures and cancerous lesions in human primary GIST and murine glioblastoma 
xenograft tissues with higher precision when compared to MSI. These findings 
emphasized the benefits of a guidance approach and a multistep workflow with the 
purpose of defining homogeneous tissue structures based on FTIR images in order to 
partition complex MSI data was developed. By registering the FTIR-derived cluster 
contours to the optical image used for MSI acquisition and interpretation, it became 
possible to identify and define molecularly distinct tissue morphologies for MALDI MSI 
guidance.  
 
In the third part of this study, the utility of the developed multimodality imaging workflow 
was exemplified in multiple disease models. Based on FTIR imaging, tumor-related 
contours that were partially invisible to conventional histopathological staining could 
be visualized in murine glioblastoma xenograft models. By registration to MSI that was 
acquired in parallel, it became possible to screen for tumor-associated mass 
signatures. For each of two tumor-segments, ten masses were identified by means of 
feature extraction using the empirical ROC curve criterion. The distribution pattern of 
all 20 masses matched the respective FTIR-segment, thus emphasizing its authenticity 
and the advantages of the developed workflow. In cases for which no a priori 
information about the spatial occurrence of disease-specific effects is available, 
automated segment-wise mass signature exploration was presented. Without user-
bias or the need of stains, specific mass shifts could be detected and linked to 
cerebellar subsections in a murine Niemann-Pick Disease, type C1 model that were 
not striking in whole-tissue fold change plots. In another approach, human derived 
GIST tissue sections of multiple patients were simultaneously clustered in order to 
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identify tumor subpopulations. Although the pathological relevance of the depicted 
groups could not be assessed conclusively, allocation results of technical replicates 
were proven consistent. Future comparison to the respective MSI imaging results may 
clarify the observed subgroup-identities.  
 
In the last part of this thesis, FTIR-guided acquisition was presented as a suitable tool 
to overcome computational challenges related to ultrahigh-resolution FTICR-MSI. The 
adjusted workflow for single-slice multimodality imaging ensures the exclusive analysis 
of pre-defined tissue structures of similar morphological makeup. In coronal and 
sagittal murine brain tissue sections, a registration efficacy of ~99% and a reduction of 
acquisition time and data load of up to 97.8% were demonstrated, thus enabling high 
resolution FTICR-MSI in cases for which the slow scan speed impedes the analysis of 
complete tissue sections or large patient cohorts. 
 
In conclusion, an automated registration pipeline that enables FTIR guidance for 
targeted acquisition or mass feature extraction in subsequent MSI experiments was 
demonstrated. Future work on the subject will likely be extended to alternate vibrational 
microscopy techniques, i.e. Raman spectroscopy that potentially discover yet unseen 
tissue morphologies, i.e. cerebellar Purkinje cells. In addition, the applicability of cluster 
evaluation techniques in order to automatically define a suitable k-value will be 
examined. Moreover, t-SNE dimensionality reduction [176] and varying cluster 
algorithms will be tested for their potential to provide better segmentation results. 
Furthermore, ultrahigh-resolution experiments of I1061T NPC1 mice will be carried out 
in ordert o verify the chemical identity of m/z 1382.9. Finally, it is noteworthy that the 
depicted registration pipeline would also enable FTIR-MSI image fusion as reported by 
van de Plas et al. [14]. It is conceivable that the additional biomolecular information of 
FTIR images greatly improves the workflow and enables forecasting distribution 
patterns of additional mass features.  
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9 SUPPLEMENT 
Table: GIST Patient metadata including tissue type, necrosis rate, sex, risk factor and mutations 
ID tissue type Nekrose (%) Sex 
Risk 
assessment 
Mutation 
A Liver 0 F High - 
AA GIST DD 0 M - cKIT exon9 
AB GIST 50 M High 
cKIT exon 9,11,17 
PDGFRA exon 12,14,18 
B Small intestine jejunum 70 M  cKIT exon 13 
C Liver 0 M  cKIT exon 9 
D Stomach / Colon 99 F  cKIT exon 11 
E Thoraxwand 5 M  
cKIT exon 11,17 
PDGFRA exon 12,14,18 
F Stomach 40 M  cKIT exon 11 
G Liver - F  
cKIT exon 9,11,13,17 
PDGFRA exon 18 
H Liver 30 M  cKIT exon 11 
I GIST 99 F  cKIT exon 11 
J Liver 30 M  
cKIT exon 11,17 
PDGFRA exon 18 
K Liver 20 M  cKIT exon 11,13 
L Liver 40 F High cKIT exon 11 
M Liver 40 M High - 
N GIST 5 M  cKIT exon 13 
O Colon 30 F High cKIT exon 9,11,13,17 
P GIST 90 M  PDGFRA exon 12 
Q Metastasis 5 M  cKIT exon 11 
R Pelvis peritoneum 0 M  cKIT exon 9,11,13,17 
S Lung - M  cKIT exon 11 
T Stomach 99 M  
cKIT wt 
PDGFRA wt 
U Liver 0 M  - 
V Peritoneum 10 F High cKIT exon 9,11,13,17 
W Liver 0 M  
cKIT exon 9,13,17 
PDGFRA exon 18 
X Stomach 20 F High cKIT exon 9,13,17,18 
Y Abdomen 30 M High cKIT exon 15 
Z Peritoneum 5 M High 
cKIT exon 11,13 
PDGFRA exon 18 
 
Curriculum Vitae 
107 
10 CURRICULUM VITAE 
PERSONALIEN 
 
Name und Vorname: Rabe, Jan-Hinrich 
Geburtsdatum: 07.08.1988 
Geburtsort: Holzminden 
Familienstand: ledig 
Vater: Dr. Holger Rabe 
Mutter: Carola Rabe 
 
 
AKADEMISCHER WERDEGANG 
 
1998 - 2007 Paul-Gerhardt Gymnasium, Abitur 
2008 – 2010 Universität Bayreuth, Biologie BSc 
2010 – 2013 Hochschule Mannheim, Biotechnology MSc 
2013 – 2017 Intitute for Medical Technology of the University Heidelberg 
and the University of Applied Sciences Mannheim, 
Dr.sc.hum. 
 
 
Acknowledgement 
108 
11 ACKNOWLEDGEMENT 
Eine wissenschaftliche Arbeit resultiert nie aus dem Schaffen eines Einzelnen. Daher 
möchte ich mich an dieser Stelle bei all den Menschen, die mich auf meinem langen 
Weg begleitet haben, ganz herzlich bedanken. Es war eine lehrreiche und spannende 
Erfahrung, die ich um nichts in der Welt missen möchte.  
Der allergrößte Dank gebührt zunächst meinem Doktorvater Prof. Dr. Carsten Hopf, 
nicht nur für die Möglichkeit, dieses spannende Projekt bearbeiten zu dürfen, sondern 
auch für seinen Rat und seine übermenschliche Unterstützung in jeder Lebenslage.  
Weiterhin möchte ich mich bei meinen Kollegen am Institut für Instrumentelle Analytik 
und Bioanalytik der Hochschule Mannheim bedanken, denn in den vergangenen 
knapp fünf Jahren fühlte ich mich stets als Teil einer großen Familie. 
Besonderer Dank in dieser Hinsicht gilt Denis Abu-Sammour, der stets gewillt war, 
konstruktive Gespräche gegen unnützes Deutsch-Wissen einzutauschen. Bei Dr. 
Sandra Schulz, Dr. Annabelle Fülöp und Dr. Christian Marsching möchte ich mich für 
ihre Freundschaft und die vielen guten Ratschläge bedanken. Dr. Bogdan Munteanu 
danke ich für seine Hingabe zur Massenspektrometrie. Ihm gebührt mein gesamtes 
heutiges Wissen in diesem Bereich. Darüber hinaus möchte ich mich herzlichst bei Dr. 
Carolina von Reitzenstein für ihre geradezu mütterliche Führsorge bedanken. 
Alexander Geisel und Malgosia Muhm danke ich für ihre tatkräftige Unterstützung. 
Auch meinen anderen Kollegen, Freunden und Weggefährten, Katrin Erich, Johanna 
von Gerichten, Julia Neitsch, Nathalie Gerhardt, Karina Ramallo-Guevara, Quin Zhou, 
Alexander Roth, Matthias Schwartz, David Weight, Peter Reis und Kevin Reinle, bin 
ich ganz besonders dankbar für eine schöne Zeit. 
Prof. Dr. Alexander Marx, Prof. Dr. Peter Hohenberger und Maria Deligiani möchte ich 
für die Bereitstellung von humanen Geweben und ihre Annotation danken. Außerdem 
möchte ich mich bei den Projekt-Teams von Dr. Elke Burgermeister und Prof. Dr. 
Michael Platten für die Vergabe von Mausxenograft-Geweben bedanken, sowie bei 
Prof. Dr. Daniel S. Ory und seinem Team für ihre Beteiligung in unserem gemeinsamen 
NPC1-Projekt.  
Diese Arbeit wurde finanziert durch das Zentrum für Angewandte Forschung ABIMAS 
des Ministeriums für Wissenschaft, Forschung und Kunst Baden-Württemberg und 
dem European Community’s Seventh Framwork Programme MITIGATE, wofür ich 
mich ebenfalls bedanken möchte.  
Zu guter Letzt gebührt mein persönlicher Dank meinen Eltern, die mich immer 
unterstützt und motiviert haben. Ich bin sicher, dass ich sie mit dieser Arbeit sehr stolz 
mache. Weiterer großer Dank gebührt meiner Paten-Oma, ohne die ich es wohl 
niemals geschafft hätte, und natürlich meinem Bruder; dafür, dass er immer für mich 
da ist. Außerdem möchte ich meiner Freundin Michaela für ihre Liebe und Zuneigung 
sowie die Korrektur meiner Arbeit danken.  
  
